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ABSTRACT 
Differential 
-xvi-
absorption of probe molecules, such as 
cellobiose and mannitol, has been used for the diagnosis and 
monitoring of patients with coeliac disease. After an oral 
dose of cellobiose and mannitol, the patient collects all 
urine passed for 5 hours. The urinary recoveries of 
cellobiose and mannitol are measured and expressed as a 
ratio which gives an indication of intestinal permeability. 
Cellobiose in urine has been measured enzymatically. Beta-
glucosidase catalyses the conversion of cellobiose to 
glucose, which is measured using a hexokinase based kit. 
This method was improved by increasing the amount of beta-
glucosidase added allowing a reduction in incubation time, 
increasing the ionic strength of the reaction buffer 
ensuring adequate pH control and careful selection of the 
hexokinase kit. These modifications led to excellent 
recoveries and precision. 
Attempts to measure mannitol enzymatically using mannitol 
dehydrogenase have been described previously utilising the 
change in absorbance produced by the reduction of NAD when 
mannitol is converted to fructose. A quick, accurate, cost 
effective and simple assay was developed on this principle. 
Mannitol dehydrogenase is not 
was therefore obtained by 
commercially available. It 
culture of 
mesenteroides and subsequent cell breakage. 
Leuconostoc 
Purification 
was carried out by ammonium sulphate fractionation and ion 
exchange chromatography. The enzyme was used to optimise an 
applicable to both 
-xvii-
manual and automated procedures. assay 
The ten minute end point assay, requiring no pre treatment 
linear up to 15 mmol/L and of urines was specific, precise, 
gave excellent recoveries. 
The results from the enzymatic mannitol assay were 
analytically validated by comparison with a trimethylsilyl 
derivatisation GLC method. They were also compared with 
results obtained by HPLC using a simple method developed 
without sample derivatisation, and a mass detector. 
After the development of .reliable and accurate enzymatic 
methods for cellobiose and mannitol levels, it was possible 
to compare the results obtained by the improved methods with 
those in which colorimetric mannitol and preliminary 
The comparison enzymatic cellobiose methods were used. 
showed that use of the 
increased the clinical 
mannitol absorption test 
disease. 
more specific improved assays 
reliability of the cellobiose/ 
in the diagnosis of coeliac 
1. INTRODUCTION 
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1. INTRODUCTION 
'The constancy of the internal environment is the condition 
for free life'. These words of the French physiologist 
Claud Bernard, dating back to the nineteenth century, show 
recognition of the need for homeostatic mechanisms to 
maintain cellular order. If this regulation of the 
environment is to take place, a constant supply of' food for 
energy is essential. For this reason, the ability to ingest 
food and process it appropriately is fundamental to all 
animals. Therefore an efficient alimentary tract is 
essential for the maintenance of good health. 
The major function of the alimentary tract (or gut) is the 
transfer of food materials from the outside world to the 
blood. Three basic processes are involved in this: 
1. Movement of food along the gut 
2. Breakdown of food into small molecules (digestion) 
3. Transfer of these molecules ~cross the gut wall into 
the body (absorption). 
To achieve these aims, the gut has evolved into a highly 
complex and specialised organ. 
Outline of structure 
The gut, throughout its length, consists of inner mucosal 
and outer muscular layers. The function of the mucosa is to 
-2-
Figure 1 - D:lqgrmat1c representation of the layers of the gut wall 
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p~oduce secretions which lubricate and digest food and to 
abso~b the digested material. 
The function of the thick muscular wall is to propel the 
food along. There are both circular and longitudinal layers 
of muscle, and between these are complex Meissner's and 
Auerbach's nerve plexuses. Three main types of nerve fibre 
serve the gut. Sensory nerves carry info~mation about the 
stretch of the gut wall, the pH and the chemical composition 
of gut contents. Parasympathetic nerves release 
acetylcholine and are responsible for stimulating the gut 
movements wh!ch propel the food along. The primary task of 
the sympathetic nerves is to control the blood supply to the 
gut, but they also stimulate the action of the smooth muscle 
sphincters which guard the entrance and exit of each section 
of the gut. 
Contraction and relaxation of the muscular layers gives rise 
to two effects. Localised contraction and relaxation causes 
churning movements (segmentation) which mixes the gut 
contents but does not move them along very much. A 
coordinated wave of relaxation followed by contraction 
causes propulsive movements (peristalsis). Stretching of 
the gut wall by the presence of food, initiates a reflex 
relaxation in front of the bolus and reflex contraction 
behind it, so pushing it along. 
After mastication, to break the food into small pieces, and 
lubrication with saliva, the food is swallowed and moved 
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down into the stomach. The main functions of the stomach 
are to store the food and pass it on to the small intestine 
in a controlled and steady manner, to begin the digestion of 
proteins and to thoroughly mix and soften the food. The 
stomach also secretes intrinsic factor which allows the 
absorption of vitamin 812 via the intestine and will 
actually absorb a few substances itself (including alcohol 
and aspirin). When the acidic contents of the stomach enter 
the duodenum, cells in the duodenal walls release the 
hormones secretin and pancreozymin into the blood stream. 
These are carried to the pancreas where they stimulate the 
release of digestive juices from the acinar cells which 
reach the duodenum via the pancreatic duct. Secretin causes 
a copious flow of watery juice while pancreozymin stimulates 
the secretion of an enzyme-rich juice. The duodenal wall 
also secretes the hormone cholecystokinin, which along with 
vagal nerve stimulation, causes contractions of the gall 
bladder. This forces bile, via the bile duct, into the 
duodenum, aiding the digestion of fats. Thus, the small 
intestine receives a mixture of largely undigested food, 
pancreatic juices and bile. The gut itself secretes a 
digestive juice but the major functions of the small 
intestine are to provide a site where digestion can occur 
and to absorb the digested food. 
The absorption of all valuable nutrients is complete by the 
time the end of the ileum is reached. The sterile, creamy-
white material, 400-600 mL per day, that is delivered to the 
large intestine (colon) consists of water, indigestible 
material and ,the remnants of dead cells which are 
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continually being shed from the gut surface. The main 
functions of the large intestine are to absorb water from 
the chyme. offer a home to a large colony of bacteria ,and 
finally store unwanted material until it can be excreted as 
faeces at a convenient time. 
Structure of the small intestine 
The small intestine can be considered to exist as three 
sections. The duodenum stretches from the stomach to the 
ligament of Treitz. The jejunum starts at the duodenum-
jejunal flexure at the ligament of Treitz but its end has no 
distinct anatomical marker. The distinction between the 
jejunum and the ileum is made more easily on functional 
grounds. Specific to the ileum are the active transport 
mechanisms for vitamin B12 and bile salts. There is also a 
secretory mechanism for bicarbonate creating a higher lumina 
pH ( pH 7.4) in the ileum compared to the jejunum ( pH 6.4). 
The intestinal surface area is greatly increased to aid 
absorption. Spiral or circular folds of Kerkring can be 
seen on the mucosal surface, They are most abundant and 
completely formed in the distal duodenum and proximal 
jejunum. The folds are up to 1 cm in height and decrease in 
number and height down the intestine, being absent in the 
ileum. The mucosal surface has a plush velvety appearance 
due to the microscopic villi. Villous shape can vary 
enormously but generally the duodenal villi are short, wide, 
thick and often leaf-shaped. In the jejunum they are 
finger-shaped and longer, up to 1.5 mm, whilst in the ileum 
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they become much shorter and more pointed. The greatest 
number, up to 40 per square centimetre, are found in the 
jejunum. Between the villi, at their bases, are the crypts 
of Lieberkuhn. These are simple tubular glands, penetrating 
the mucosa. Their main functions are the secretion of 
digestive juices and cellular proliferation by mitosis to 
regenerate the epithelial cells lost at the tips of the 
villi. 
The intestinal mucosa consists of three layers. The 
muscularis mucosa is the deepest and consists of a sheet of 
smooth muscle 3-10 cells thick. The middle layer, the 
lamina propria, is the sub epithelial connective tissue 
space. It is composed of a mixture of cells including 
fibroblasts, macrophages, plasma cells, lymphocytes, 
eosinophils and mast cells, and non cellular elements such 
as collagen and reticular fibres which provide support for 
the epithelium. It has a system of blood and lymph vessels, 
nerve fibres and strands of smooth muscle, which serve the 
epithelium. The lymphoid cells in the lamina propria serve 
as a protective barrier against bacteria and foreign 
substances. The third layer, the surface epithelium, is a 
continuous sheet of columnar cells packed together. There 
is a mixture of cell types - enterocytes, goblet cells and 
lymphoid cells with Paneth and enterochromaffin cells in the 
crypts. The cells are at different stages of maturity, 
with immature cells in the crypts, mature cells at the 
middle of the villus and the old and dead cells at the 
exfoliation area at the villous tips. The mature 
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enterocytes are responsible for absorption whilst the 
immature crypt cells are the major source for the intestinal 
secretion of fluid and electrolytes. 
The mature enterocyte has a specialised construction to aid 
absorption. The free luminal surface of the cell contains 
the striated brush border which can be seen under light 
microscopy. This border consists of finger-like microvilli 
which are about I pm long and number about 3,000 per cell. 
These greatly increase the luminar surface area of the cell. 
The microvilli are coated with fuzz or glycocalyx which is 
thought to provide a filter against bacteria and foreign 
materials and help in the 
layer and microclimate. 
formation of an unstirred water 
The unstirred water layer remains fairly undisturbed by the 
mixing and propulsive movements of the intestine and so has 
the effect of preventing the chyme from freely reaching the 
epithelial cells. This forms the principal barrier to lipid 
soluble molecules. Beneath the unstirred water layer, the 
walls of the epithelial cells are composed mainly of lipid 
and therefore hinder the passage of water soluble molecules. 
Transfer across biological membranes 
There are two categories of transport across biological 
membranes. 
Macrotransfer is a discontinuous process of movement of 
material including large molecules and particles. 
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Endocytosis involves the ingestion of material by forming a 
membrane bound vesicle from the plasma membrane including 
pinocytosis, micropinocytosis and phagocytosis. Exocytosis 
occurs when cells eject substances or 
bound vesicles. 
fluid from membrane-
Microtransfer is movement at a molecular or ionic level. It 
is a continuous process and includes the movement of amino 
acids, sugars, drugs and ions. There are two types of 
microtransfer - passive and active. 
Passive transport refers to the net movement of substance 
down an electrochemical gradient. 
Active transfer involves movement 
electrochemical gradient. 
of substance against an 
Cell membranes are composed of a bilayer of lipid sandwiched 
between protein layers. This makes it very difficult for 
water soluble substances, for example, hexoses, amino acids 
and ions to move in and out of the cytoplasm unaided. They 
thus combine with a structure in the membrane which ferries 
them across. This carrier mechanism allows faster movement 
than would be predicted for simple diffusion from the oil-
water solubility coefficient or when compared with molecules 
of similar size and lipid solubility. It also causes 
competition amongst similar molecules for transfer and 
allows specificity, to the extent that optical isomers are 
transported at different rates. The rate of transfer 
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gradually reaches a limit as the concentration of substance 
increases. 
Carrier transport is highly relevant to intest inal 
absorption. If the carrier"s movement is energised by 
metabolism, active transport can be achieved but if the 
carrier only moves a solute according to the prevailing 
electrochemical gradient, then facilitated diffusion occurs. 
Although there is little doubt that a simple diffusion of 
solutes across the epithelium also occurs, the exact 
mechanisms by which this happens are not understood. 
It is postulated that enterocyte membranes are perforated by 
water-filled pores which allows small hydrophilic molecules 
to pass through. Although such pores have not been 
identified morphologically, it is considered that they allow 
the passage of molecules up to approximately 230 x 10-3 nm3 
(a little larger than monosaccharides or mannitol which has 
a molecular radius of 0'4- nm), (l). Larger molecules such as 
disacchar.ides (disaccharide molecular radius is 0·5 nm) are 
absorbed less efficiently and probably pass through the 
intercellular spaces via tight junctions between the cells 
at the villous tips. It is p'ossible however that there are 
multiple pathways for diffusion, even allowing some uptake 
of antigenic macromolecules. 
Coeliac disease 
Coeliac disease (or gluten-sensitive enteropathy) is one of 
the commonest chronic gastrointestinal diseases. It is the 
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condition in which the small intestinal mucosa develops 
abnormalities on contact with dietary gluten. Coeliac 
disease (CD) can present in both children and adults. 
Symptoms include poor growth, weight loss, malnutrition, 
diarrhoea, steatorrhoea, anaemia, behavioural disturbances, 
bleeding (due to vitamin K deficiency), bone pain (due to 
osteomalacia) or any combination of these. 
The symptoms of CD were first described in the 1st or 2nd 
century AD by Aretaeus, whilst the work of Samuel Gee, 
published in 1888, gave a very accurate description of the 
condition. However, it was not until the 1950s that the 
therapeutic effect of a gluten-free diet was discovered. At 
the same time, the value of diagnosis by intestinal biopsy 
for confirmation of the presence of mucosal lesions, was 
recognised (2, 3). 
The intestinal lesions are usually found in the duodenum and 
jejunum but may also appear in the ileum. Histological 
examination shows a flat appearance of the mucosa with 
atrophy of the villi and hypertrophy of the crypts. Surface 
epithelial cells may have damaged or lost microvilli, 
increased vacuolation, swelling of the mitochondria and 
increased numbers of lysosomes. The immature crypt cells 
are usually structurally normal. Infiltration of the lamina 
propria and surface epithelium by inflammatory cells is 
usually increased and the structure of the basement membrane 
may be damaged. The lesions are widely distributed in the 
small intestine but there is some variation in the severity 
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of the damage. 
It is thought that the crypt cell hyperplasia is an attempt 
to compensate for increased loss of villous enterocytes. 
Cytokinetic studies show that in active CD, the cell cycle 
time is halved, proliferation and maturational epithelial 
compartments are increased and cellular production is 
elevated to two- to six-fold (4). 
Structure of gluten and mechanism of toxicity 
The role of wheat and rye in CD was demonstrated in 1950. 
Further work showed that the toxicity was due to the gluten 
fraction, which makes up 90% of the protein found in wheat 
flour (5). 
Wheat gluten consists of equal quantities of glutenin and 
gliadin and it is the latter that is toxic to patients with 
CD. The gliadin fraction consists of at least 40 different 
proteins which have been sub-divided into four groups -
and omega based on their alpha, beta, gamma 
electrophoretic mobility. The alpha fraction seems to be of 
particular importance in the formation of mucosal lesions in 
CD. 
The mechanism by which gliadin causes damage in CD is 
unclear. It is possible that gliadin is intrinsically toxic 
to the enterocytes and that patients with CD lack the 
ability to detoxify it. However, it is equally possible 
that coeliac patients metabolise gluten in such a way that 
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it forms a toxin. Recentlyan immunological basis for the 
disease was postulated (6) when it was discovered that there 
was a region of amino acid homology between A-gliadin (a 
major alpha gliadin component) and a protein extracted from 
human adenovirus serotype twelve (which invades the 
intestinal tract). 
Many studies have shown that there is a tendency for CD to 
run in families. About 10% of first degree relatives of 
coeliacs have jejunal biopsies that show abnormalities. 
This is higher than would be expected in the general 
population but lower than would be expected by classical 
Mendelian genetics. It is possible that CD is transmitted 
as a dominant gene with incomplete penetrance or as two 
distinct separately inherited genes. Alternatively, there 
may be a genetic-environmental interaction which is more 
complex than simply the introduction of dietary gluten. 
Possible factors involved in· the aetiology of CD are 
summarised in Figure 2, while Figure 3 illustrates the 
mechanisms that are probably pathogenic in CD (7). 
Diagnosis of coeliac disease 
In 1970, the European Society for Paediatric 
Gastroenterology proposed three criteria for the diagnosis 
of CD which are widely accepted. These require 
demonstration of: 
1. Mucosal abnormality by biopsy, usually performed near 
'i 
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Figure 2 - Possible mechanisms involved in the aetiology of coeliac disease 
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Explanation of Figure 2 Possible mechanisms involved in 
the aetiology of coeliac disease (7) 
It has not yet been proven whether gluten is intrinsically 
toxic to human intestinal mucosa (premise # 1) or only 
becomes so because of some inappropriate response in the CD 
patient (premise # 2). A basic enzymopathy in CD could 
occur within the gastrointestinal lumen, at the mucosal 
surface or within the interior of the enterocyte (defects 
IA/IB, 2A/2B or 4A/4B). Alternatively, abnormal immuno-
reactivity or altered surface glycoproteins in CD might 
impart toxic pot ent ia I to otherwise benign cereal 
constituents (defects 2C and 2D). Finally, an abnormality 
of mucosal barrier function might allow exposure of 
intestinal sites normally protected from toxic or 
immunogenic gluten components (defect 3). 
,~ 
CNS? 
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" 
Figure 3. - Possible mechanisms involved in the pathogenesis of coeliac disease 
Possible defects 
lA, 2A or 4A 
Failure to 
detoxHy 
gluten 
Erfects on other 
cell types 
k 
I' 
, 
Crypt cell 
hyuerplasia 
Possible defects 
IB,. 2B or 4B 
Production of 
deleterious properties 
of gluten pep tides 
" ...-_____ 'C!:" ______ -, 
Extra and/or intra 
cellular damage to enterocytes 
,11 
Proliferation of 
" enterochromaffin celLs 
I' 
Possible defect 
3 
Inappropriate exposure 
of sensitive sites to 
gluten fragments 
Possible defect 
2C or 2D 
Abnormal binding of 
gluten to enterocyte 
surface membranes 
Mucosal damage by 
immune mechanisms of 
L-____ ~'~ action (antibodies, " 
" complement, sensitised If-------\ 
Mu;osal damage 
by lectin-like 
mechanisms of 
cells, lymphokines, action 
null cells. etc. 
Cell death of enterocytes ~,~---------------------------~ 
Flat mucosal lesion of coeliac diseas~ 
-16-
Explanation of Figure 3 Possible mechanisms involved in 
the pathogenesis of coeliac disease (7) 
The aetiological possibilities previously identified in 
Figure 2 might induce the 'flat' mucosal lesion of CD in a 
variety of ways. An enzymopathy, (defects lA/lB, 2A/2B or 
4A/4B), which leads to a failure to detoxify gluten or its 
conversion to a neotoxin, might directly result in 
enterocyte damage and death. Alternatively, an intrinsic 
abnormality of mucosal permeability (defect 3) might 
inappropriately expose sensitive sites to gluten and result 
in enterocyte damage either by direct toxic mechanisms or 
via intermediation of the intestinal immune system. 
Finally, abnormal host immunoreactivity (defect 2C) or 
perturbations of membrane glycoproteins (defect 2D) might 
lead to binding of gluten constituents to the enterocyte and 
damage by immune or lectin-like mechanisms. Similar 
mechanisms might also affect other cell types, 
• 
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the ligament of Treitz, in a patient I'dth evidence of 
malabsorption. 
2. Clinical and biopsy evidence of improvement on a 
gluten-free diet. 
3. Relapse after the reintroduction of gluten into the 
diet, which should be evident within 2 years of the 
reintroduction. 
However, there 
Some patients, 
are problems with such general criteria. 
usually adults, do not respond to the gluten-
free diet and it is not yet certain whether this represents 
a complication of CD or a different disease entity . 
Conversely, other patients in whom a gluten-free diet has 
induced remission, do not relapse for several years after 
the reintroduction of gluten. The use of biochemical tests, 
including permeability tests, have further complicated 
matters, with the identification of biochemical 
abnormalities in some patients who are clinically in 
remission. Therefore, there is some controversy about the 
definition and diagnostic criteria for CD, and a less 
restrictive definition which emphasises the 
abnormal mucosa may be more appropriate. 
Biochemical investigation of coeliac disease 
importance of 
It has long been known that the presence of mucosal lesions 
in CD is associated with biochemical alterations, such as 
abnormal absorption of xylose, fat and glucose and depressed 
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levels of iron, folate and carotene in the blood. There 
have been many attempts to utilise such variations to 
develop specific diagnostic tests for CD. 
Antibodies to dietary proteins are found in the circulation 
of both normals and coeliacs. It is thought that food 
protein antigens crOSs the intestinal mucosa and are cleared 
from the body after forming immune complexes with specific 
antibodies. However, if the mucosa is damaged, antigen 
absorption is enhanced and antibody production is increased. 
Several food protein antibody levels have been measured 
including crude gliadin, alpha-gliadin and casein, using RIA 
and ELISA techniques (8, 9). Raised levels of such 
antibodies are found in various gastrointestinal disorders, 
but increased anti alpha-gliadin antibodies has a high 
specificity for CD. 
In 1967 it was shown that there is a reduction in the 
passive absorption of small molecules via the jejunum in CD 
(10) . It was thought that this was due to a reduction in 
the size of the aqueous pore s . Later work using 
polyethylene glycols, monosaccharides and mannitol confirmed 
reduced absorption but suggested that it might be due to 
decreased surface area rather 
permeability. However, since 
than a change 
the area of 
in epithelial 
the intestinal 
mucosa cannot easily be measured, it is generally considered 
acceptable to assume that in CD, the intestinal permeability 
to small molecules is reduced. At the same time there is a 
paradoxical increase in mucosal permeability to 
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disaccharides ( 11 ) . This has also been demonstrated with 
SlCr-EDTA and is most obvious when the test solution is 
hypertonic (12). 
The association of decreased permeability to small molecules 
and increased permeability to larger ones forms the basis of 
the differential absorption test. A small molecule such as 
mannitol or rhamnose and a disaccharide such as cellobiose 
or lactulose, are given as an oral dose in hypertonic 
solution. The urinary recovery of each probe molecule is 
then determined in a timed urine collection and the result 
is expressed as the recovery ratio. 
The use of probe molecules to 
particularly when used in 
assess intestinal absorption 
combination, gives clear 
separation of normalsand abnormals. They are simple to 
use, non-invasive and well tolerated by patients. They can 
be used both for screening purposes and for monitoring the 
response of coeliac patients to the introduction of a 
gluten-free diet. They may also be used to demonstrate 
persistent gluten sensitivity in treated coeliacs by means 
of a gluten challenge (13). 
Choice of suitable probe molecules for studying intestinal 
absorption 
For many years intestinal absorption has been investigated 
by the use of probe molecules. The selection of suitable 
probe molecules is governed by several factors. The 
absorption of lipid soluble molecules and those with 
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affinity for active transport mechanisms is less affected by 
mucosal disease than that of solutes absorbed by passive 
diffusion. This is because the active transport mechanisms 
are so efficient that it is only possible to demonstrate 
abnormal absorption when severe and widespread disease is 
present. However, the less efficient simple passive 
diffusion mode of absorption becomes markedly deficient even 
in mild disease. Therefore in order to maximise the 
sensitivity of the test, the probe molecules should be 
absorbed passively. They must be non-toxic, not metabolised 
after absorption and not otherwise present in the body, and 
there must be suitable assay techniques available to detect 
them. 
Polyethylene glycols (PEG) of various molecular weights have 
been used. PEG is non toxic, not metabolised and not 
ordinarily present in the body. However, the assay 
techniques are complex and difficult and the exact mode of 
absorption of PEG has not been established. It is possible 
that it is not absorbed by simple passive diffusion. 
Radioactive probes have been used to study intestinal 
permeability. 5lCr-EDTA is thought to be absorbed in the 
same way as disaccharides and can be assayed with a gamma 
counter. However, it is also absorbed in the colon and does 
not appear to give results that agree with some of the sugar 
probe molecules (14). 14C-mannitol has also been used to 
assess permeability and can be assayed isotopically using a 
beta-counter. This sugar alcohol is absorbed in the same 
way as monosaccharides and so is a sensitive indicator of 
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permeability. However, the use of radioactive materials, 
while valuable as a research tool, is not ideally suited to 
routine use, particularly as a screening test, since special 
assay equipment and handling areas are required, and because 
of the complex licencing procedures associated with the 
administration and disposal of such substances. 
have been used as probes. Various carbohydrates 
Monosaccharides and 6 carbon sugar alcohols, for example 
mannitol (molecular radius about 40 nm), are of a suitable 
size to assess permeability through the major diffusion 
channel for small molecules while disaccharides are suitable 
for studying larger pathways. High molecular weight dextran 
polymers have been used to investigate permeability to 
macromolecules. For many years, xylose absorption has been 
the most widely used means of investigating intestinal 
function (15). 
pentose sugar) 
metabolised to 
However, it is now known that xylose (a 
is partially actively absorbed and is 
a variable extent after absorption, factors 
which detract from its usefulness as a probe. Mannitol and 
L-rhamnose are now used as monosaccharide type probes. 
Lactulose, cellobiose, platinose and melibiose have all been 
used as disaccharide probes. However, any test system which 
relies on the use of one probe molecule is limited by 
variables such as gastrointestinal transit time, renal 
function and the considerable individual variation that is 
found in intestinal absorption. Differential sugar 
absorption tests, with results expressed as a disaccharide/ 
monosaccharide excretion ratio, provide much more reliable 
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information and wider discrimination between normals and 
abnormals. In CD, lactulose/mannicol or cellobiose/mannitol 
:~S:5 gi\'8 resulzs ~hat cor~Ela~e well WiLh mucosal recover}" 
as shown by hisLOlogy. They may be more sensi~ive ~han 
biopsy for moni~oring the response to a gluten-free diet, 
since patients with a high intra epithelial lyrnphocyte count 
but ocherwise normal histology have abnormal cellobiose/ 
mannitol ratios ( 1 6 ) . 
and sugar alcohols is 
A disadvantage of 
the complexity of 
the use of sugars 
their measurement 
paper, gas or high performance liquid usually by 
Chromatography, 
viidespread use. 
which has undoubtedly prevent.ed more 
A large number of studies have been published in which 
intestinal permeability has been investigated by means of 
sugar based probe molecules. The use of a monosaccharide, 
or mannitol in combinat.ion with a disaccharide, is a common 
technique but the choice of which particular sugars to use 
is less clear cut. Alt.hough L-rhamnose and L-arabinose have 
been used, mannicol appears to be the most widely used 
molecule of monosaccharide t.ype. Cellobiose and lactulose 
are the most. commonly used disaccharide molecules, wi th 
approximat.ely equal numbers of reports opting for each one. 
A recent study (17) which compared the results of 
cellobiose/mannitol testing with chose of lactulose/mannitol 
in the same group of patients, found the absorption ratios 
obtained from t.he cwo combinaiions cO be very similar. 
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The dosage of the probe molecules given to patients show 
good agreement between different centres. Typically 5 g of 
cellobiose or lactulose is given with 2 g of mannitol. 
These are dissolved in 100 mL of water and the solution is 
made hypertonic by the addition of other sugars, commonly 
lactose and sucrose (20 g of each). Glucose has also been 
used as an osmotic filler, and in areas where lactase 
deficiency is common, the lactose may be omitted and sucrose 
only given (40 g). The test solution used by most centres 
has an osmolality of 1,500 mmol/kg. 
The patient, having fasted 
solution and then collects 
over night, 
urine which 
drinks the test 
is used for the 
analysis. Physiological studies of the absorption of 
mannitol and disaccharides (18) show that a carefully 
standardised urine collection time of between 4 and 6 hours 
gives best results. A 5 hour collection period is 
recommended by most authors. The specimens can be stored at 
-20·C until analysis, and are stable for at least one year, 
but some centres do use a preservative such as thiomersal or 
chlorohexidine gluconate. 
Table 1 shows the cellobiose and mannitol recovery values 
obtained from 6 studies. It can be seen that all 6 studies 
have very similar values for the normal cellobiose/mannitol 
ratio, although the methodologies vary and recoveries of the 
individual probes show some variation. 
'. 
Table 1 - Cellobiose and mannitol recovery results obtained from 6 studies 
REF NO PRINCIPAL METHODOLOGY METHODOLOGY NORMAL RECOVERY NORMAL RECOVERY NORMAL RANGE 
AUTHORS USED USED RANGE RANGE CELLOBIOSE/MANNITOL 
CELLOBIOSE MANNITOL CELLOBIOSE % MANNITOL % RATIO 
16 Strobel S Hydrolysis by Spectrophotometric 0.54 23.3 Mean = 0.023 
Brydon WG fi -glucosidase; . Corcoran and Page :!: 0.16 :!: 5.0 SD= :!: 0.007 
detection of glucose 
. 
by hexokinase kit 
, 
19 Blood J Hldrolysis by Spectrophotometric 0.49 27.0 Mean = 0.018 
I"' -glucosidase; modified Corcoran 0.15-0.95 15.4-37.1 0.005-0.031 
detection of glucose and Page 
by glucose oxidase kit 
13 Hamilton I Quantitative paper Spectrophotometric 0.32 19.6 Mean = 0.0172 
Cobden I chromatography Corcoran and Page ! 0.20 ! 8.5 0.002-0.04 
Rothwell J 
20 Hamilton I Quantitative paper Spectrophotometric 0.32 19.6 Mean = 0.016 
Fairris GM chromatography Corcoran and Page SD = 0.2 SD = 8.3 0.0006-0 •. 038 
Rothwell J 
14 Martines D Hydrolysis by Gas liquid 0.32 22.5 0.017 ! 0.003 
Morris AI -glucosidase; chromatography ! 0.04 ! 2.7 .Upper limit of 
Gilmore A detection of glucose as trimethylsilyl 0.041 (mean + 2 SD) 
by hexokinase kit derivative 
21 Juby ID Quantitative paper Spectrophotometric Not stated Not stated 0.004-0.028 
Rothwell J chromatography Corcoran and Page 
Axon ATR 
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Assay technigues for sugar-based probe molecules 
The use of 
intestinal 
sugar-based 
permeability, 
molecules in 
particularly 
tests 
as 
to assess 
mono and 
disaccharide combinations, is increasing because passively 
absorbed sugars fulfil many of the requirements of probe 
molecules. The ease with which a potential probe molecule 
can be assayed is very important, particularly if the 
permeability test is aimed at being introduced for routine 
use. Where 2 or more molecules are used, it is even more 
vital that they can be assayed with ease. 
Paper and thin 
for the 
layer chromatography have been used for many 
identification and estimation of sugars in years 
ur ine . However, considerable skill and experience are 
required to obtain reliable results. Quantitation is 
carried out either by means of a scanning densitometer or by 
eluting the spots from the plate and measuring the amount of 
colour photometrically (22). Precision and sensitivity tend 
to be poor'. Chromatographic techniques are very time 
consuming with each run taking several hours, and require 
the use of unpleasant and toxic organic solvents and stains. 
They do, however, have the advantage of allowing the 
simultaneous estimation of several sugars in virtually any 
combination. 
Although unt il recently, paper chromatography has been the 
most widely used technique for the estimation of sugars, 
there have been various chemical methods used. Many colour 
reactions have been employed, some of which react with. 
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furfural (produced from the sugar by heat and acid) and 
others which are based on reduction by Benedict's reagent. 
None of these 
Glucose, which 
are specific and sensitivity is poor. 
is present in normal urine in small 
quantities (the average concentration is 0.03 mmol/L) is a 
major source of interference. Attempts have been made to 
overcome this by precise timing of the reaction or 
fermentation using yeast. Attempts to measure the sugar 
alcohol, mannitol, date back to the 1940s. Chemical methods 
suffer from the same lack of specificity and sensitivity as 
those for sugars. 
Colorimetric methods for measuring mannitol 
Various chemical methods have been used for measuring 
mannitol in blood and urine. One method published in 1943 
was based on the reduction of ferricyanide by mannitol in a 
strongly alkaline solution. Another utilised titration to 
estimate the amount 
oxidation of mannitol 
of periodate 
in a hot acid 
consumed 
solution. 
after the 
The most 
widely used chemical method is that of Corcoran and Page, 
published in 1947 (23), which is also based on the oxidation 
of mannitol by periodic acid. formaldehyde, one of the 
products of this 
form a purple 
reaction, reacts with chromotropic acid to 
complex which absorbs at 570 nm. The 
oxidation of mannitol is carried out in acid solution to 
minimise interference, as the oxidation of other substances 
including glucose, occurs only very slowly under these 
conditions. The reaction is stopped after 5 minutes by the 
addition of stannous chloride. 
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Despite carrying out the reaction in optimum conditions, the 
method remains non specific and any substance oxidised by 
periodic a~jd may interfer~. serum. the mos~ impo~tant 
interference is due to glucose whi15~ in urine it is due to 
'nan fermentable reducing subs~ance5' (23). 
unpleasant to perform because the reagents are strongly 
acidic and require boiling for colour development. 
hazardous and impossible to automate. 
It is 
A modification (17) of the Corcoran and Page technique 
utilises a variation of the Hantzsch condensation reaction. 
The formaldehyde produced by the oxidation of mannitol 
reacts with ammonia and acetyl acetone (2 ,4-pentanedione) to 
produce a yellow coloured compound, 3 ,5,diace:yl-l, 4 -
dihydrolutidine which absorbs at 405 nm. However, 
specificity remains a problem. Fasting urines often have 
high blank values due to variable amounts of interfering 
substances making correction difficult. The use of 
creatinine to correct for these variations in concentration 
does not improve results. 
The use of enzymes as analytical tools has become very 
widespread. They are specific in their action and methods 
can often be automated making them very useful for routine 
assays. Enzymatic assays may involve one reaction, a series 
of linked reactions or may be coupled with some other. 
mechanism such as antibody-antigen reactions. The specific 
action of enzymes makes them particularly useful for the 
assay of sugars, whose similar chemical properties mean 
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that chemical analYSis without prior separation is 
difficult. The most common use of enzymes for analysis of 
sugars has been in the measurement of blood or serum glucose 
using hexokinase or glucose oxidase. However, as interest 
in intestinal permeability has grown, attempts have been 
made to develop enzymatic assays for other mono or 
disaccharides and mannitol. 
Mannitol dehydrogenase 
A highly specific enzyme, mannitol dehydrogenase (MOH), 
which catalyses the pyridine nucleotide-dependant oxidation 
of O-mannitol to O-fructose is present in a number of 
organisms. The NAO dependant enzyme (mannito1:nicotinamide 
adenine dinucleotide 2-oxidoreductase; EC 1.1.1.67) has been 
purified from Lactobacillus brevis (24, 25), Leuconostoc 
mesenteroides (26), Absidia glauca (27) and Rhodococcus 
erythropo1is (unpublished). The NAOP dependant enzyme 
(mannitol:nicotinamide adenine dinucleotide phosphate 2-
oxidoreductase, EC 1.1.1.38) has been detected in a number 
of fungi and purified from Aspergillus parasiticus (28). 
An enzymatic technique for the measurement of mannitol was 
described in 1975 (25), in which MOH was used to OXidise 
mannitol and the fructose formed was monitored 
colorimetrically. However, the technique was slow and 
tedious to perform. Yamanaka in 1975 described purification 
of the enzyme from Leuconostoc mesenteroides and used the 
MOH for the measurement of fructose by monitoring the 
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decrease in absorption at 340 nm as NADH was converted to 
NAD (26). Blomquist et al (24) published a kinetic method 
in 1981 for the measurement of serum mannitol, monitoring 
the change in absorbance at 340 nm. The MDH was purified 
from Lactobacillus brevis using column chromatography. In 
1989, Lunn et al (30) published a method for urine mannitol 
using an end point assay to monitor the change in absorbance 
at 340. nm. The enzyme was isolated from Leuconostoc 
mesenteroides using an extraction procedure based on that of 
Yamanaka. 
These methods utilising MDH are a great improvement over the 
colorimetric mannitol methods but are still far from 
suitable for routine use. 
Mannitol method of Blomquist et al (24) 
This report described a kinetic assay using MDH purified 
from Lactobacillus brevis. 
approximately 50 g of cells. 
A 30 L culture produced 
The cells were suspended in 
phosphate buffer and disrupted by sonication for 15 minutes 
in the presence of glass beads. The sonicate was 
centrifuged and the clear supernatant applied to a DE 23 
column. The enzyme was eluted from the column using a 
linear salt gradient. The active fractions obtained were 
pooled and then added to a mixture of celite 545 and solid 
ammonium sulphate. 
before being poured 
solution was used 
The slurry was stirred for several hours 
into a column. An ammonium sulphate 
to wash the column and the enzyme was 
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eluted using a linear reverse salt gradient. 
fractions obtained were pooled and then stored at 
The active 
-20·C. 
Blomquis~ d8sc~ibed 2 assays. The first was to determine 
MDH activiLy. The enzyme extract was added to a solution of 
mannitol and NAD dissolved in tris buffer at pH 8.0. NADH 
formation was recorded at 340 nm. The second assay was for 
measuring mannitol levels. The sample containing mannitol 
was added to a solution of bicine pH 9.0 containing MDH and 
NAD. The absorbance at 340 nm was recorded for 5 minutes to 
monitor NADH formation. In each assay, the initial velocity 
was determined by constructing a reaction curve and taking a 
tangent to it. A kinetic assay was chosen by Blomquist et 
al because mannitol, having a high Michaelis constant (40-60 
mmol/L), would require either large quantities of enzyme or 
long incubation times for complete conversion to fructose. 
The mannitol assay was developed for use with serum 
specimens, and no interference could be demonstrated with 
sugars or polyols that might be present in serum, such as, 
glucose, sorbitol, inositol or xylitol. No sample 
preparation was required. The reason for using tris buffer 
for the MDH assay and bicine for the mannitol assay is not 
stated. 
A full description of the enzyme purification procedure and 
the assay are described in the Methods section. 
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Growth and purification procedure for MDH described by 
Yamanaka 
In 1975, Yamanaka (26) described a method for the growth 
extraction and purification of MDH from Leuconostoc 
mesenteroides and also an assay for fructose in which the 
MDH is utilised. Leuconostoc mesenteroides ATC 9135 was the 
strain of organism suggested. This is a heterofermentative 
species which produced the highest enzyme yields when grown 
in static culture for 16 hours in a D-glucose medium. A 
50 L culture produced about 94 g of cells. The cells were 
disrupted by grinding with alumina and the enzyme was 
dissolved in phosphate buffer. Cell debris and alumina were 
removed by centrifugation. Nucleic acids and organelles 
were precipitated by the addition of protamine sulphate. 
Several selective protein precipitations followed using 
different degrees of ammonium sulphate saturation 
alternating with redissolving the precipitates and dialysing 
out excess ammonium sulphate. Precipitation with cold 
acetone and a final ammonium sulphate saturation procedure 
allow the enzyme to crystallise (and recrystallise if 
required). (Full details of this procedure can be found in 
the Methods section). 
The mannitol method of Lunn et al (30) 
This is an end point assay using MDH purified from 
Leuconostoc mesenteroides. The growth, extraction and 
purification of the enzyme were based on the procedure 
described by Yamanaka (26). 
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The mannitol assay was adapted for use on a Cobas Bio 
automatic centrifugal analyser. The sample containing 
mannitol was added to a solution of NAD in a glycine/ 
hydrazine buffer at pH 8.6 and mixed. MDH was added as a 
start reagent and the rise in absorbance at 340 nm was 
monitored over a 5 minute period. The change in absorbance 
was a measure of the amount of NADH produced and directly 
proportional to the mannitol concentration in the sample. 
The reaction was carried out at 40°C. (Full details of the 
procedure are described in the Methods section). 
The assay was precise, specific and easy to perform. 
However, the reaction was subjected to product inhibition by 
fructose requiring correction for high fructose levels. The 
method was non linear at both low and high concentrations of 
mannitol, resulting in a very narrow working range. The 
enzyme purification procedure, based on Yamanaka, is time 
consuming, requires considerable skill and is impractical 
for producing small amounts of enzyme. 
Cellobiose method of Strobel et al 
In 1984 Strobel et al (16) published an enzymatic technique 
for the measurement of urinary cellobiose USing the enzyme 
beta-glucosidase, which converts cellobiose to D-glucose. 
The resultant glucose was assayed using a hexokinase method 
in which the increased absorbance at 340 nm was monitored 
and NADP was converted to NADPH (see Figure 4). 
Both the enzymes, beta-glucosidase and the hexokinase kit 
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were obtained commercially. The conversion of cellobiose to 
glucose requires a 2 hour incubation at 37°C in order to 
reach completion. Correction for endogenous urinary glucose 
was achieved by incubation of urine with acetate buffer 
alone, followed by assay of the mixture by the hexokinase. 
method. 
Determination of the glucose has also been carried out using 
a glucose oxidase method kit (19) in which a pink 
quinonimine is produced and the absorbance at 500 nm is 
measured (see Figure 4). 
Automation of the glucose measurement by either method is 
straightforward, gives improved precision and a quicker 
turnround time. (Full details of this procedure are found 
in the Methods section). 
Measurement of sugar.,§._E.Y GL~nd_HPLC 
Many methods have been described for the measurement of 
sugar based molecules by GLC and HPLC. With respect to 
advantage of intestinal permeability studies, the 
chromatographic techniques is ability to measure several 
sugars simultaneously, in different combinations. 
GLC 
The two prerequisites for GLC of an analyte are volatility 
and thermostability under the experimental conditions. 
Since sugars are not naturally volatile, they must be 
derivatised to a form that is. A major problem with 
2. 
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Figure 4 - Chemistry of the enzymatic cellobiose method 
Cellobiose Beta-glucosidase> 2 D-glucose 
1. D-glucose + ATP 
--------> Glucose-6-phosphate + ADP 
Glucose-6-phosphate 
--------> 6-phosphogluconate 
NADP NADPH 
Absorbance at 340 nm 
D-glucose + -------> Gluconic acid + 
1,5 dimethyl-2-phenyl-4 
Aminopyrazdone 
2,4,6-tribromophenol 
--------> Brominated quinonLm1ne 
(pink coloured) 
Absorbance at 500 nm 
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derivatisation is the formation of multiple products from 
each sugar. This may be due to anomerisation or to the 
formation of both furanose and pyranose rings. To 
circumvent this, an extra step must be added which involves 
conversion of the sugars to acyclic oximes, nitrites or 
alditols. 
acetates 
Hydroxyl groups can then be derivatised to either 
or trimethylsilyl esters, forming a single 
asymmetric derivative for each sugar. 
the detector of choice. 
Flame ionisation is 
Although GLC is quite widely used for measurement of sugars 
and sugar based molecules, the necessary 'cleaning up' of 
urine specimens and preparation of derivatives is time 
consuming and imposes constraints on the processing of large 
batches of samples. 
High Performance Liquid Chromatogra~~~LHPLCl 
Volatility of the analyte is not a requirement of HPLC, so 
it is possible to analyse samples with a minimum of 
preparation. However, both pre and post column 
derivatisation may be employed to aid separation and improve 
sensitivity. Several types of detectors are available and 
have been used for the detection of sugars. 
Many of the HPLC methods described for the determination of 
sugars utilise refractive index detection. These detectors 
are widely available and are simple to use, but have limited 
sensitivity and specificity. They are affected by changes 
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in ambient temperature and can only be used for isocratic 
separation. 
rhamnose and 
intestinal 
A refractive index method for lactulose, 
mannitol for use in the assessment of 
permeability has been described ( 31 ) . 
Pretreatment of urines involved addition of saturated sodium 
hydroxide followed by mixing with an ion exchange resin. 
Water is the mobile phase 
column operated at 8S·C is 
and a CHO-620 cation exchange 
used for separation. However, 
the precision and recoveries are poor, with small responses 
at the concentration levels encountered. 
The absorption of ultra violet (UV) light by some sugars, 
has been used as a means of detection after HPLC separation. 
Because the absorbance is weak, sensitivity may be improved 
by derivatisation. Nitrobenzoate (32) and benzyloxime-per-
benzoyl (33) derivatives have both, been used for the 
quantitation of mono and disaccharides in biological fluids. 
However, the derivatisation procedures are both time 
consuming and potentially hazardous, involving extensive use 
of organic solvents at high temperatures. 
The use of Electro Chemical (EC) detectors for the 
quantitation of sugars has been investigated. Glassy carbon 
and dropping mercury electrodes are unsuitable as the 
veryhigh potentials required produce high blank values and 
poor sensitivity. However, a home made nickel electrode has 
been found to give promising results (34). More 
importantly, the recent introduction of the Pulsing 
Amperometric Detector (PAD) has revived interest in the use 
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of electro chemistry for the measurement of sugars. 
The PAD has a gold working electrode and a silver/silver 
chloride reference electrode. A series of three potentials 
is applied to the system in a repeating wave form. The 
first 'detection' potential is followed by an oxidising 
potential that cleans the electrode surface, The third 
potential reduces the gold oxide formed to gold, so that the 
cycle is repeated. The use of varying potential leads to 
greatly increased sensitivity, specificity and response 
times. 
A PAD method has been described for the determination of 
lactulose and mannitol levels (35). Pre treatment of urines 
involves dilution with deionised water and desalting with an 
ion exchange resin, but no derivatisation is required. The 
mobile phase is sodium hydroxide and a dionex HPIC-AS6 anion 
exchange column at 20·C is used for separation. Between 
batch precision of less than 5%, recoveries of approximately 
100% and linear responses for both lactulose and mannitol 
were obtained. All the from 0.5 to 3,000 mg/L 
interest were eluted in less than 15 minutes. 
peaks of 
The rapid 
analysis time coupled with short sample preparation suggests 
that PAD would be of great interest as a routine method. 
However, the high price of the detectors puts the technique 
out of the reach of many laboratories. 
The evaporative light scattering (or universal mass) 
detector has been introduced recently. The effluent from 
the separation column enters the detector via a nebuliser, 
It is converted to a fine mist by a stream of carrier gas _ 
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usually air or nitrogen - and then enters a drift tube which 
is temperature controlled. The mobile phase is evaporated, 
leaving only small particles of non volatile solute. The 
cloud of solute passes through a light beam (a tungsten bulb 
or laser) causing light scattering which is amplified by a 
photo multiplier. The measured light is proportional to the 
amount of sample in the light scattering chamber. The mass 
detector is non specific and responds to any non volatile 
solutes, so good separation of compounds of interest is 
important. However, it can be used for a wide variety of 
applications, with gradient elutions, has no solvent front 
interference and is much more sensitive than refractive 
index detectors. The use of the mass detector has been 
suggested for the determination of urinary sugars for the 
assessment of intestinal permeability (36, 37). The 
technique has been used (38) but required pre treatment of 
samples by thin layer chromatography (TLC). 
Summary of introduction 
The theoretical basis for an absorption test utilising two 
probe molecules has been established as has the clinical 
need for diagnostiC testing of this nature. The miscellany 
of methods available for the measurement of sugar based 
molecules is an indication of dissatisfaction with their 
reliability. The development of methods giving good 
performance coupled with ease of practice would enable much 
wider use of the absorption test. The enzymatic methods 
proposed have the advantages of extreme ease of measurement 
and minimal specialised equipment while a.simple HPLC method 
has the advantage of simultaneous analYSis of both probe 
molecules. 
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2 .1 .1 . Materials 
Folin-Ciocalteu's protein method 
Folin-Ciocalteu reagent BDH 
Copper sulphate BDH 
Sodium tartrate - BDH 
Sodium carbonate - BDH 
Bovine serum albumin (for standards) 10 g/dL 
chemicals 
Sugar alcohols and sugars used for specificity studies 
(All from Sigma Chemicals) 
Lactose 
Galactose 
Sucrose 
Fructose 
Sorbitol 
Inositol 
Arabinose 
Maltose 
Ribose 
Xylose 
Glucose 
Glycerol 
Mannitol assays (enzymatic) 
Sigma 
Leuconostoc mesenteroides ATCC 9135 - ATCC 12301, Park lawn 
Drive, Rockville, Massachussets, USA. 
SpeCial peptone L72 - Unipath (Oxoid) Limted, Wade Road, 
Basingstoke, Hampshire, PG24 OPW 
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Yeast extract L21 - Unipath (as above) 
Sodium acetate - BOH 
Magnesium sulphate (MgS04.7H20) - BOH 
Sodium chloride - BOH 
Manganese sulphate - BOH 
O-glucose - BOH 
Tris (hydroxymethyl)-methylamine - BOH 
Hydrazine - BOH 
Glycine - BOH 
Potassium dihydrogen phosphate - BOH 
AIumina type A-S A2039 - Sigma Chemicals 
NAO NISll - Sigma Chemicals 
NAO sodium salt N-063Z - Sigma Chemicals 
Hexokinase (from baker's yeast) H-4S02 - Sigma Chemicals 
ATP disodium salt A-2383 - Sigma Chemicals 
Bicine B-3876 (N,N-bis(2-hydroxyethyl)glycine) Sigma 
Chemicals 
Mannitol (for standards and recoveries) - Sigma Chemicals 
Zinc sulphate - Sigma Chemicals 
Modified Corcoran and Page 
Potassium periodate BOH 
Suphuric acid - BOH 
Stannous chloride (anhydrous) - BOH 
Hydrochloric acid - BOH 
Ammonium acetate - BOH 
Glacial acetic acid - BOH 
Acetyl acetone - BOH 
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Cellobiose assay 
Beta-glucosidase - Sigma Chemicals 
Beta-glucosidase - Biozyme Laboratories Limited, Gilchrist-
Thomas Estate, Blaenavon, Gwent, NP4 9RL 
Acetic acid - BDH 
Sodium acetate - BDH 
Glucose kits: 
Glucose oxidase reagent 
Burgess Hill, West Sussex 
Glucose oxidase reagent kit 
Northern Ireland 
American Monitor UK Limited, 
Randox Laboratories Limited, 
Hexokinase reagent kit 
above) 
- Randox Laboratories Limited (as 
Glucose oxidase reagent - Technicon 
Hexokinase kit (UV) - Sigma Chemicals 
D + cellobiose (for standards and recovery solutions)-
Sigma Chemicals 
D + glucose (for standards and recoveries) - BDH 
HPLC cellobiose and mannitol assay 
Acetonitrile, HPLC grade 
Walkerburn, Scotland 
Rathburn Chemicals Limited, 
Water, HPLC grade - Rathburn Chemicals Limited (as above) 
Mannitol (for standards) - Sigma Chemicals 
Cellobiose (for standards) - Sigma Chemicals 
Ribose - Sigma Chemicals 
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2.1.2. Equipment 
Ultrasonic probe - MSE, via Fisons Limited, Loughborough 
Mickle cell disintegrator - H. Mickle, Gomshall, Surrey 
Heating block Grant Instruments (Cambridge) Limited, 
Barrington, Cambridge 
Cobas Bio centrifugal analyser-
Welwyn Garden City, Hertfordshire 
Coleman 55 spectrophotometer 
Beaconsfield, Buckinghamshire 
Roche Products Limited, 
Perkin Elmer Limited, 
Centrifuges, Minifuge 2 - Heraeus Equipment Limited, 9 Wates 
Way, Brentwood, Essex 
Centrifuge, Beckman GP centrifuge 
HPLC system ACS Limited, The Arsenal, Heapy Street, 
Macclesfield, Cheshire 
Ternary Gradient Pump, model 252 - ACS Limited (as above) 
Evaporative analyser, model 750/14, mass detector - ACS 
Limited (as above) 
Column spherisorb 5NH2 25 cm x 4.6 mm, pp 40701 - HPLC 
Technology Limited, 
Cheshire 
10 Waterloo Street, West Macclesfield, 
Guard column - HPLC Technology Limited (as above) 
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2.1 .3 . Materials for patient testing 
Suppliers for patient test solution: 
D+Cellobiose 
D mannitol 
Lactose 
Sucrose 
Idis Limited, 
51 High Street, 
Kingston on Thames, 
Surrey. 
East Anglia Chemicals Limited, 
Hadleigh, 
Ipswich, 
Suffolk. 
Thornton and Ross Limited, 
Linthwaite, 
Huddersfield. 
Ordinary household granulated sugar 
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2.2.1. Total protein assay 
This total protein method uses the Folin-phenol reagent as 
described by Lowry et al in 1951 (39). 
Reagent preparation 
Sodium carbonate (0.38 mol/L): 4 g dissolved in 100 mL 
deionised water. 
Sodium tartrate (0.17 mol/L): 4 g sodium tartrate 
«CHOH.COONa)2.2H20) dissolved in 100 mL deionised water. 
Copper sulphate (0.08 mol/L): 2 g copper sulphate 
(CuS04.SH20) in 100 mL deionised water. 
Alkaline copper sulphate solution: prepared by adding 1 mL 
copper sulphate solution and 1 mL sodium tartrate solution 
to 100 mL sodium carbonate solution. 
Folin and Ciocalteu's phenol reagent: the stock reagent 
(BDH) was diluted 1 in 3 with deionised water for use. 
Standards 
The stock standard (Sigma) was bovine serum albumin at a 
concentration of 100 g/L. This was diluted in 0.9% sodium 
chloride to produce working standards covering the range 
0-100 mg/l 00 mL. 
Procedure 
0.5 mL sample or standard was added to 5.0 mL alkaline 
copper sulphate solution. After mixing, the solution was 
incubated at 4S·C for 15 minutes. 0.5 mL of diluted Folin 
and Ciocalteu reagent was added. The solutions were mixed 
immediately and allowed to stand for 15 minutes at room 
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temperature. At the end of this period, the absorbances 
were measured at 720 nm against a blank of distilled water. 
The assay is non-linear and a typical standard curve can be 
seen in Figure 5. 
0.9 
0.8 
0.7 
0.6 
0.5 
0.4 
5 
" 
0 
C\J 
t- 0.3 
..., 
'" (]) 
u 
" 0.2 
'" .0 <. 
0 
t1l 
.0 
.. 0.1 
-47-
Figure 5 - Typical standard curve for the Folin-Lowry 
protein method 
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Protein mg/lOO mL 
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2.2.2.a. Reagent preparation and procedure for the culture 
of Leuconostoc mesenteroides by Yamanaka's technique 
Culture medium 
Prepared by dissolving the following in distilled water: 
1% W/V peptone 
0.2% yeast extract 
0.02% magnesium sulphate 
0.001% sodium chloride 
0.0002% manganese sulphate 
1% O-glucose 
The organism was inoculated into 8 mL of the medium and 
incubated overnight at 30'C. The whole of this culture was 
transferred to 400 mL of the same medium and incubated for 
24 hours. This was then transferred to 10 L of medium and 
incubated for 16 hours. The cells were harvested by 
centrifugation (about 20 minutes at 2,000 g). 
Reagent preparation and procedure for the-purification of 
MOH from Leuconostoc mesenteroides b~Yamanaka's technique 
Phosphate buffer 
50 mmol/L containing I mmol/L mercaptoethanol. 6.8 g/L 
potassium dihydrogen phosphate and 0.07 mIlL 
2-mercaptoethanol were dissolved in deionised water and the 
pH adjusted to 7.0 using concentrated hydrochloric acid. 
Protamine sUlphate 
2 g dissolved in 100 mL deionised water. 
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Saturated ammonium sulphate 
Solid ammonium sulphate dissolved in 20 mL deionised water. 
Purifica~ion procedure 
The cells obLained af~er centrifugation of the medium were 
washed with 1 L of phosphate buffer and recentrifuged. The 
washed cells were disrupted by grinding them with a pestle 
and mortar using levigated alumina. Small portions of cells 
were ground at a time, adding enough alumina to form a 
gritty paste. 1 L of phosphate buffer was then added to the 
paste to dissolve the enzyme. The cell debris and alumina 
were removed by centrifugation. 46 mL of protamine sulphate 
solution was added dropwise to the enzyme solution. Thi s 
was allowed to stand for about 1 hour and then centrifuged 
and the precipitate (nucleic acid remnants) discarded. To 
the supernatant (about 950 mL) was added 674 g of solid 
ammonium sulphate, to give 100% saturation and precipitate 
all of the protein. The ammonium sulphate was added 
gradually and the mixture was allowed to stand for 1 hour 
before the precipitate was collected by centrifugation. It 
was redissolved in phosphate buffer (28.5 mL) and dialysed 
overnight, with continuous stirring against 1 L of buffer. 
This dialysate was designated ammonium sulphate fraction 1. 
The .following day, fraction 1 (about 45 mL) was again 
treated with solid ammonium sulphate. Initially 12.8 g of 
ammonium sulphate was added and the precipitate formed 
discarded. A further 4.62 g was added (giving 50-65% 
saturation) . 
redissolved in 
The precipitate from this was 
4.0 mL phosphate buffer and 
collected, 
dialysed 
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overnight in 1 L of buffer. This was designated fraction 
I I . 
The following day, fraction II was adjusted to pH 6.0 with 
0.2 mol/L acetic acid. Acetone (3.4 mL), cooled to -20~C 
was added dropwise and stirred gently. The precipitate was 
removed immediately by centrifugation at -lO'C (10 minutes 
at 2,000 
4.3 mL of 
g). To the supernatant (about 10 
cold acetone was added, (giving 
mL), a further 
50% solution). 
The precipitate from this was collected and redissolved in 
phosphate buffer. 6.8 g of ammonium sulphate was added to 
give 80% saturation. The precipitate was collected and 
redissolved in 5.0 mL phosphate buffer and dialysed 
overnight against 1 L of buffer (acetone fraction). 
Crystallisation of the enzyme can be carried out with the 
acetone fraction. Saturated ammonium sUlphate solution is 
added dropwise until the solution becomes turbid. The 
turbidity is removed by centrifugation and the solution left 
at 4'C overnight to allow the first crystals to appear. The 
crystals are collected 
2.0 mL phosphate 
by centrifugation and redissolved in 
buffer and dialysed overnight. 
Recrystallisation is carried out by the same procedure. 
NB Yamanaka used this extraction technique for the 
purification of enzyme obtained from 50 L of medium which 
yielded 94 g of washed cells. The technique was scaled down 
for smaller culture volumes. 
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2.2.2.b. Reagent preparation and procedure for the 
purification of MOH by Blomguist's method 
Phosphate buffer (buffer A) 
25 mmol/L phosphate, 1 mmol/L EOTA and 1 mmol/L mercapto-
ethanol. Prepared by 
dihydrogen phosphate, 
acid (EOTA) and 0.07 
dissolving 3.4 g of potassium 
0.29 ethylene-diamine-tetra-acetic 
mL 2-mercaptoethanol in 800 mL 
deionised water, adjusting the pH to 6,8 with 5 mol/L sodium 
hydroxide and then making up to 1 L. 
Phosphate buffer plus 0.5 mol/L potassium chloride 
Prepared by dissolving 37.28 g potassium chloride in 1 L of 
buffer A. 
Ammonium sulphate (NH4)2S04 
3 mol/L.396.39 g ammonium sulphate dissolved in and made up 
to 1 L with deionised water. 
Purification of MOH - method of Blomquist 
The sonicated bacteria were centrifuged at 10,000 g for 30 
minutes. All subsequent stages of the purification were 
carried out at The clear extract obtained by 
centrifugation was applied to a 30 cm x 1 cm column of DE23 
equilibrated at pH 6.8 with buffer A. 
The column was then washed with 200 mL buffer A. 
The MOH was then eluted with a linear salt gradient prepared 
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from 200 mL buffer A and 200 mL buffer A + 0.5 mol/L 
potassium chloride. 
The active fractions were pooled and further purified by 
ammonium sulphate precipitation. 
The pooled fractions (about 250 mL) were mixed with 10 g 
celite 545 and solid ammonium sulphate to give a final 
concentration of 3 mol/L. 
The slurry was stirred overnight at 4·C. It was then poured 
into a glass column and allowed to settle. It was then 
washed with 50-100 mL of 3 mol/L ammonium sulphate. 
MDH activity was eluted by using a linear reverse gradient 
from 3 mol/L to 1 mol/L ammonium sulphate. 
The active fractions were pooled and stored at -20·C. 
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2.2.3. Measurement of MOH activity 
2.2.3.a. Method of Yamanaka 
Acetate buffer 
50 mmol/L, pH 5.3. 6.8 g sodium acetate was dissolved in 
800 mL deionised water. The pH was adjusted to 5.3 with 
glacial acetic acid and the volume made up to 1 L. 
O-Fructose 
1 mol/L. 9 g of O-fructose dissolved in 50 mL deionised 
water. 
NAOH 
10 mmol/L. 0.0665 g NAOH dissolved in 10 mL deionised 
water. 
Procedure 
The assay was carried out by combining 100 ~L of acetate 
buffer, 6 ~L of NAOH and 30 ~L of enzyme extract, 
sufficiently diluted in acetate buffer to give an absorbance 
change of less than 0.109A per minute. The reaction was 
started by the addition of 30 ~L of fructose solution and 
absorbance readings were taken every 30 seconds for 5 
minutes. 
One unit of MOH activity oxidises 1 ~mol of NAOH per minute 
per mL. (1 ~mol NADH in 1 mL solution at 340 nm gives 6.22 
absorbance units in a 1 cm light path). Molar extinction 
coefficient = 6.22 x 10-1 . 
2.2.3.b. 
Tris buffer 
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Method of Blom~st 
50 mmol(L, pH S.6. Prepared by dissolving lS.15 g 
trishydroxymethyl aminomethane in SOO mL deionised water. 
The pH was adjusted to S.6 with concentrated hydrochloric 
acid and the solution was made up to a final volume of 1 L 
with deionised water. 
0.5 mol/L mannitol in tris buffer 
Prepared by dissolving 9.1 g mannitol in 100 mL of tris 
buffer. 
NAD solution 
10 mmol(L. Prepared by dissolving 0.685 g of NAO (sodium 
salt) or 0.663 g NAD in 100 mL deionised water. 
Procedure 
The assay to assess MOH activity was carried out by 
combining 2.5 mL of 0.5 mol(L mannitol solution (in tris) 
and 0.2 mL of NAO. The reaction was started by adding an 
aliquot of enzyme solution, sufficient to give an absorbance 
change of about 0.1 per minute at 340 nm. The reaction was 
monitored for 5 minutes. 
One unit of MDH activity catalyses the reduction of 1 ~mol 
of NAD per minute per mL. (1 ~mol NADH in 1 mL solution at 
340 nm = 6.22 absorbance units in a 1 cm light path). 
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2.2.3.c. Modified method of Blomguist - MDH assay used 
The MDH assay described by Yamanaka (above) was not used 
because it takes place at acid pH and in the reverse 
direction, ie, fructose to mannitol. It was considered that 
an assay utilising the forward reaction, ie, mannitol to 
fructose at approximately pH 8.6 would be more appropriate 
since this was the reaction in which the enzyme would 
eventually be used. 
The MDH assay described by Blomquist (above) was much more 
suitable. It did however, use large volumes of solutions 
and have a much lower concentration of coenzyme (NAD) in the 
final reaction mixture than that of Yamanaka. It was 
modified to reduce the volumes used and increase the NAD 
concentration. 
Reagents 
These were made up as described by Blomquist (above). 
Procedure 
0.5 mL of mannitol in tris buffer was added to 0.2 mL NAD in 
a 1 cm spectrophotometer cuvette. The reaction was started 
by adding 50 ~L of enzyme, diluted in tris buffer 
sufficiently to give an absorbance change of about 0.1 
absorbance units per minute at 340 nm. 
The change in absorbance was monitored every 30 seconds over 
a period of 5 minutes. 
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2.2.4. Measurement of mannitol levels 
In the cellobiose/mannitol absorption test, an oral dose of 
2 g of mannitol is given. In normal controls, there is a 
mean recovery of 19% in the 5 hour urine collection while in 
coeliac patients, this recovery drops to very low levels. 
With a mean 5 hour urine volume of 375 mL, a standard curve 
for mannitol over the range 0 to 15 mmol/L should allow 
measurement of most urine specimens. 
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2.2.4.a. Measurement of mannitol levels - Blomguist 
Bicine buffer 
0.12 mol/L, pH 9.0. Prepared by dissolving 19.58 g bicine 
(N,N bis(2 hydroxyethyl)glycine) in 800 mL deionised water, 
adjusting the pH to 9.0 with sodium hydroxide and making the 
volume up to 1 L. 
Working reagent 
1.2 mmol/L NAD and enzyme extract. 0.0822 g NAD sodium salt 
is dissolved in 100 mL bicine buffer. Enzyme extract is 
added to this. Blomquist recommends that a concentration of 
between 5 and 25 mg/L of protein is added (275-1,374 
units/L) 
Procedure 
1.5 mL of working reagent is added to a cuvette and the 
absorbance monitored at 340 nm for 2-3 minutes to ensure a 
stable reading. 50 ~L of sample or mannitol standard is 
added to start the reaction. The change in absorbance is 
monitored for 5 minutes. 
NB - The volumes suggested by Blomquist have been halved 
because of the smaller cuvette volume available. 
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2.2.4 .b. Measurement of mannitol levels - Lunn 
Glycine/hydrazine buffer 
0.4 mol/L glycine and 0.5 mol/L hydrazine. 3 g glycine is 
dissolved in 50 mL deionised water. 2.5 mL of 85% aqueous 
hydrazine hydrate is added. The buffer is adjusted to 
pH 8.6 with hydrochloric acid, made up to 100 mL and stored 
in a dark bottle. 
NAD solution 
75 mg of NAD is dissolved in 10 mL of glycine/hydrazine 
buffer immediately before use. 
Enzyme solution 
MDH is extracted by Yamanaka's technique from Leuconostoc 
mesenteroides. The purified enzyme is dissolved in 
phosphate buffer and used at a concentration of about 
50 U/mL. 
Assay procedure 
Approximately 100 ~L of sample is placed in a Cobas Bio 
sample cup and loaded on to the analyser. Three aqueous 
mannitol standards are used with values of 250, 500 and 
1,000 mg/L (1.37, 2.74 and 5.49 mmol/L), The analyser is 
programmed as shown in Table 2. During operation, 20 ~L of 
sample 
added 
or sta~dard plus 10 
to 40 ~L of NAD 
~L of water (as wash out) is 
solution. After mixing, the 
absorbance at 340 nm is recorded. 15 ~L of MDH is added 
together with a further 20 ~L of water (as wash out). 
Acceleration and mixing occurs and the increase in 
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absorbance at 340 nm is monitored every 30 seconds for 5 
minutes. The results are calculated from the formula: 
(AN - AAux) sample - (AN - AAux)RB x F 
Where -
AN is the measured absorbance during the run 
AAux is the absorbance reading after the incubation time 
RB is the reagent blank 
F is the factor which is automatically calculated from the 
within-run standards. 
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Table 2 - Programme parameters for mannitol assay on the 
Cobas Bio (method of Lunn et all 
(ALPHA) + MANNITOL 
1 Units mg/L 
2 Calculation factor 0 
3 Standard 1 250 
4 Standard 2 500 
5 Standard 3 1,000 
6 Limit 1,000 
7 Temperature ( 0 C) 40 
8 Type of analysis 6 
9 Wavelength (nm) 340 
10 Sample volume (ilL) 20 
11 Di luent volume ( ilL ) 10 
12 Reagent volume ( ilL ) 40 
13 Incubation time (sec) 10 
14 Start reagent volume (ilL) 15 
15 Time of fir st reading (sec) 0.5 
16 Time interval (sec) 30 
17 Number of readings 10 
18 Blanking mode 1 
19 Printout mode 1 
NB Diluent volume refers to the sample probe rinse 
(distilled water). A further 20 ilL distilled water is added 
to the cuvette (not listed). Reagent volume refers to 
volume of buffer-NAD reagent. Start reagent volume refers 
to volume of MDH. 
2.2.4.c. 
point 
Buffer 
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Measurement of mannitol levels - optimised end 
Tris(hydrochloric acid 0.5 mol(L at pH 8.6 containing 
magnesium (5 mmol(L) as magnesium sulphate. 
Enzyme reagent 
Partially purified D-MDH (from Leuconostoc mesenteroides). 
Enzyme was diluted with buffer to 20 u(mL (automated 
procedure) or 133 u(mL (manual procedure). 
Coenzyme reagent 
NAD, hexokinase and ATP 
buffer at 17.2 mmol(L, 10 
(automated procedure) or 
(Sigma Chemicals) were added to 
u(mL and 18 mmol(L respectively 
6.25 mmol(L, 3.64 u/mL and 
6.55 mmol(L respectively (manual procedure). 
Mannitol standard 
Aqueous standard of 8 mmol(L mannitol was used. 
Procedure 
The sample or standard containing mannitol was mixed with 
coenzyme reagent and warmed to 37°C. MDH was then added and 
the absorbance monitored to end point (10 minutes). 
Automated procedure 
The reaction parameters for an end-point assay on the Cobas 
Bio analyser are shown in Table 3. Parameters 12 and 14 
refer to the 
respectively. 
volumes of coenzyme reagent and enzyme 
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Table 3 - Programme parameters for mannitol assay on the 
Cobas Bio (optimised end point method) 
(ALPHA) + MANNITOL 
1 Units mmol/L 
2 Calculation fact or 0 
3 Standard 1 8.0 
4 Standard 2 8.0 
5 Standard 3 8.0 
6 Limit 12 
7 Temperature ( 0 C ) 37 
8 Type of analysis 6 
9 Wavelength (nm) 340 
10 Sample ( ilL ) 5 
11 Di luent volume ( Il L ) 20 
12 Reagent volume (ilL) 50 
13 Incubation time (sec) 60 
14 Start reagent vol ( \1 L ) 50 
15 Time of first reading (sec) 0.5 
16 Time interval ( sec) 30 
17 Number of readings 21 
18 Blanking mode 1 
19 Printout mode 1 
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Manual procedure 
1.0 mL coenzyme reagent and 20 ~L sample or standard were 
mixed, warmed to 37°C and the absorbance (Aa) measured at 
340 nm. 50 ~L of enzyme solution was added; the reaction 
incubated for a further 10 minutes at 37°C and the 
absorbance measured (AI). The mannitol concentration of the 
sample was calculated from the absorbance change (AI - Aa) 
by comparison with the mannitol standard. 
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2.2.4.d. Measurement of mannitol levels modified 
Corcoran and Page 
?~riodic acid reaaent 
.0.03 molar po~assium periodate (6.90 giLl in 0.25 molar 
sulphuric acid. 
Scannous chloride reagent (SnC12) 
Approximately 0.125 molar stannous chloride (anhydrous form, 
23.8 g/L) dissolved in 0.3 molar hydrochloric acid. The 
exact concentration of stannous chloride required is found 
by titrating it with periodic acid reagent and adjusting the 
concentration until 10 mL stannous chloride reagent is 
equivalent to 10.2 mL periodic acid reagent. For the 
titration, 5 mL of concentrated hydrochloric acid is added 
to the stannous chloride reagent and starch solution is used 
as the indicator. 
This reagent must be prepared fresh before each assay. 
However, it is not necessary to carry out the titration each 
time, provided the same batch of stannous chloride is used. 
Acetyl acetone reagent 
Stock buffer. A 2 molar ammonium acetate buffer is prepared 
by dissolving 154 g ammonium acetate and 8 mL glacial ace~ic 
acid in distilled water and making the volume up to 1 L. 
The pH should be adjusted to 5.0 if necessary. 
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Working reagent 
1.5 mL acetyl acetone is added to 50 mL of stock buffer 
solution and the mixture is vigorously shaken until the 
acetyl acetone dissolves completely. This reagent must be 
prepared fresh before each batch. 
Procedure 
2 mL of sample or standard is added to 0.5 mL periodic acid 
reagent, mixed and allowed to stand at room temperature for 
8-10 minutes. 0.5 mL stannous chloride reagent is added and 
the tubes mixed again. (A precipitate is formed at this 
stage) . 2 mL of acetyl acetone reagent is added, followed 
by further mixing and incubation at 6S'C for 30 minutes. 
After centrifugation to remove the precipitate, the 
absorbances of the supernatants are read at 405 nm. 
A standard curve over the range 0-0.165 mmol/L is prepared 
(see Figure 6). All urines are diluted 1 in 150 to reduce 
the mannitol concentration to within the standard curve 
range. 
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Figure 6 - Typical standard curve for the modified Corcoran 
and Page mannitol method 
0.028 0.055 0.083 0.110 0.138 0.165 
Mannitol mmol/L 
2.2.5. 
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Measurement of cellobiose levels 
Stock buffers 
0.1 mol/L acetate buffer, pH 5.0. 
0.035 moles (2 mL) glacial acetic 
Prepared by dissolving 
acid and 0.065 moles 
(8.84 g) sodium acetate in 1 L of deionised water. 
0.5 mol/L acetate buffer, pH 5.0. Prepared by dissolving 
0.175 moles (10 mL) glacial acetic acid and 0.325 moles 
(44.2 g) sodium acetate in 1 L of deionised water. 
Working beta-glucosidase reagent 
Preparations of solid beta-glucosidase were obtained from 3 
suppliers. Each bottle of enzyme had an activity stated in 
terms of units/mg solid. The activity units used by each 
supplier were as follows: 
BDH unit definition - one unit will liberate 1.0 ~mole 
glucose per minute at pH 5.0 at 37°C. 
Sigma unit definition one unit will liberate 1.0 
pmole glucose per minute at pH 5.0 at 37°C. 
Biozyme unit definition - one unit will liberate 1.0 ~g 
glucose per minute at pH 5.0 at 35°C. 
(All activities stated were based on the use of salicin as 
subst rate) . 
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For the purpose of this thesis, all beta-glucosidase 
concentrations are expressed in terms of Sigma units (1 
Sigma unit = 180 x biozyme units, no correction for 
temperature change has been made). 
Different amounts of beta-glucosidase were used for the 
working reagent (see Results section). The optimised method 
uses 100 Sigma units/mL in 0.5 mol/L acetate buffer. 
Table 4 shows the stated activities of beta-glucosidase from 
different sources and batches. 
Glucose measurement kits 
All kits were reconstituted according to the manufacturer·s 
instructions. 
Standard curves 
In the cellobiose/mannitol absorption test, an oral dose of 
5 g of cellobiose is given. In normal controls, there is a 
mean recovery of approximately 0.32% of cellobiose in the 5 
hour urine collection while in coeliac patients this 
increases to a mean recovery of approximately 0.97%. Hence, 
between approximately 15 and 20 mg cellobiose will be 
present in an average 5 hour urine volume of 375 mL. If 
complete conversion of cellobiose to glucose takes place 
during the incubation with beta-glucosidase, then 0.3 to 0.8 
mmol/L glucose will be produced in the incubation mixture. 
The glucose method was found to be linear up to 2.0 mmol/L 
allowing the use of a single aqueous standard of 2.0 mmol/L 
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glucose in the assay. Recovery solutions and quality 
control specimens were prepared by the addition of varying 
amounts of cellobiose, up to 1.5 mmol/L, to urines collected 
from normal volunteers. 
The cellobiose assay (optimised) 
0.1 mL urine or aqueous cellobiose standard is added to 
0.1 mL of working beta-glucosidase reagent, mixed and 
incubated at 37"C. To obtain blank values (correcting for 
any endogenous glucose), 
added to 0.1 mL 0.5 
0.1 mL of urine and 
mol/L acetate buffer, 
standard is 
mixed and 
incubated at 37"C. After 15 minutes, the incubation 
mixtures are analysed for glucose content. 
The glucose assay 
In all of the glucose kits used, there 
reagent which was pre warmed to 37oC 
was one working 
before adding the 
sample or standard. After mixing and incubation at 37°C for 
5 minutes, the change in absorbance was measured. The 
glucose oxidase methods are measured at 500 nm while the 
hexokinase based methods are monitored at 340 nm. 
The glucose measurement could be performed manually or 
easily adapted to an automatic analyser such as the Cobas 
Bio. 
Manual glucose assay 
0.1 mL of the incubation mixture, obtained above, was mixed 
with 1.0 mL of prewarmed hexokinase reagent. The mixture 
Table 4 - Manufacturers stated activities for beta-glucosidase 
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was incubated at • 37 C for 5 minutes and the absorbance read 
at 340 nm. 
Automated glucose assay 
The assay was adapted to the Cobas Bio centrifugal analyser. 
The programme parameters are shown in Table 5. 
An end point analysis type was selected in which the system 
pipettes 200 ~L of reagent into the reagent cavity of each 
cuvette. Acceleration and mixing occurs and after an 
incubation time of 60 seconds, the absorbance of the reagent 
in each cuvette is read and stored. 50 ~L of sample is then 
added along with 20 ~L of diluent (deionised water). 
Further acceleration and mixing occurs and then initial 
absorbances are read followed by 19 more readings taken at 
30 second intervals. 
The results are automatically calculated from the equation: 
«AN - AAux) sample - (AN - AAux) RB) x F = glucose (mmol/L) 
Where -
AN is the measured absorbance during the run 
AAux is the absorbance reading after the incubation time 
RB is the reagent blank 
F is the factor which is automatically calculated from the 
within-run standards. 
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Calculation of cellobiose results 
The glucose method is linear over the desired concentration 
range, allowing the use of a single standard. 
As stated above, the Cobas Bio analyser will automatically 
calculate glucose concentrations. 
the following formula can be used: 
In the manual procedure, 
Since 1 cellobiose molecule is equivalent to 2 glucose 
molecules, a division by 2 is required to convert mmol/L of 
glucose to mmol/L cellobiose. However, the urines or 
standards are diluted by a factor of 2 when the beta-
glucosidase reagent is added. Therefore, in practice, the 
glucose result, mmol/L, is equivalent to the cellobiose 
level, mmol/L and no conversion is required. 
Test = 
(test abs 340 - rgt blank abs 340) x std cone (glue) 
(std abs 340 - rgt blank abs 340) 
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Table 5 - Programme parameters for the cellobiose method on 
the Cobas Bio 
1 Uni ts mmol/L 
2 Calculation factor 0 
3 Standard 1 concentration 2.0 
4 Standard 2 concentration 2.0 
5 Standard 3 concentration 2.0 
6 L imi t 2.0 
7 Temperature ( 0 C ) 37.0 
8 Type of analysis 1 
9 Wavelength (nm) 340 
10 Sample volume (~L) 50 
11 Diluent volume (~L) 20 
12 Reagent volume (~L) 200 
13 Incubation time (sec) 60 
14 Start reagent volume (~L) 0 
15 Time of fir st reading ( sec) 0.5 
16 Time interval ( sec) 30 
17 Number of readings 20 
18 Blanking mode 1 
19 Printout mode 1 
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2.2.6. HPLC measurement 
Internal standard 
1 mL ribose in aqueous solution. la mmol/L. 
Standards 
Mannitol - 0 to 20 mmol/L in aqueous solution. 
Cellobiose o to 20 mmol/L in aqueous solution. 
Procedure for measurement of cellobiose and mannitol by HPLC 
This HPLC method was based on the manufacturer's application 
notes, 
The mobile phase 
mixture. This 
0.5 mL/minute to 
was acetonitrile and water in an 80/20 V/V 
mixture was recycled through the pump at 
prime the guard column and column prior to 
analysis for several hours or over night. One hour before 
analysis, the detector was switched on and allowed to warm 
up to 65°C. 
temperature, 
When the detector was at the correct 
it was connected up to the column. At thi s 
point the mobile phase solution enters the detector and is 
vapourised, so it is essential to ensure adequate 
ventilation of the system. The pump speed is set to 
1.5 mL/minute for the analysis of samples. 
Sample preparation was by centrifugation of urines for 5 
minutes at 2,000 g and the addition of la ~L of internal 
standard solution to 1 mL of sample or standard. 
this was injected onto the column. 
20 ilL of 
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The data from the detector was received and analysed by the 
system integrator and could be printed out when required. 
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2.2.7. GLC measurement 
Measurement of urinary mannitol by GLC was carried out using 
a modification of the method of Laker and Mount (40). 
The samples were prepared by mixing 1 mL of urine and 1 mL 
of internal standard (inositol). Zerolit DM-F resin (H 
acetate form) was added to occupy 50% of the volume of the 
solution. After mixing, the samples were centrifuged and 
1 mL of supernatant was dried at 50°C under a stream of air. 
Trimethylsilylated derivatives were obtained by adding a 
mixture of pyridine:trimethylchlorosilane:bis-trimethylsilyl 
trifluoroacetamide (in a ratio of 10:1:1) to the dried 
samples and heating at 55°C for 45 minutes. 
The derivatised product was injected directly onto a HP-l 
column operated at 190°C. Hydrogen was used as a carrier 
gas. Flame ionisation (at 350°C) was used for detection and 
quantitation was by peak height measurement. The method is 
linear over a sample mannitol concentration of 0.5 to 33.0 
mmol/L and 
97%. The 
the mean recovery of mannitol added to urine is 
within-batch imprecision at a sample mannitol 
concentration of 8 mmol/L is 1.9%. 
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2.2.8. Protocol for the cellobiose/mannitol absorption 
test - instructions to patients 
On the evening before the test do not eat or drink anything 
after midnight. 
The following morning, make up the test solution by emptying 
the contents of both bottles into a cup or glass. Then fill 
both of the bottles with tap water and add to the powder. 
Stir until all of the powder has completely dissolved and 
the solution is clear (hot water may be used since this will 
make the powder dissolve more quickly). If necessary, warm 
the solution in a saucepan until dissolved. 
When the test solution is ready, the test is begun by 
emptying the bladder (and discarding the urine down the 
toilet). Then drink all of the test solution and put about 
half an inch of water into the bottom of the glass, stir 
gently and drink this too. The test solution should all be 
drunk in less than 10 minutes. 
Collect all urine passed for 5 hours after drinking the 
solution. During the first 2.5 hours, one or two cups of 
water, black coffee or tea (without sugar) should be drunk. 
Return the completed 5 hour urine collection to the 
Biochemistry Laboratory, at Derbyshire Royal 
City Hospital, between 9.00 am and 5.00 
Friday. 
Infirmary or 
pm, Monday to 
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Summary of instructions 
1. Fast from midnight on day before test. 
2. Dissolve the 2 bottles of powder in water. 
3. Empty bladder. 
4. Drink solution. 
5. Collect urine for 5 hours. 
6. Return completed urine collection to laboratory. 
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3, RESULTS 
3.1. Cell growth and enzyme purification 
3.2. Development of a kinetic assay for mannitol 
3.3. Development of an end point asay for mannitol 
3.4. Optimisation of the cellobiose assay 
3.5. Evaluation of the HPLC method for mannitol 
and cellobiose 
3.6. Assessment of the clinical significance of the 
improved enzymatic methods for mannitol and 
cellobiose 
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3 .1. Cell growth and enzyme purification 
Growth of Leuconostoc mesenteroides by Yamanaka's method 
Using the technique described by Yamanaka (see Methods 
section), a small pilot batch of Leuconostoc mesenteroides 
ATCC 9135 was grown. The procedure was scaled down to give 
a final culture volume of 2 L. From this, 15 mL of washed 
bacterial cells were obtained. The yield was assessed from 
the weight of 1 mL of washed cells, dried over night at 
50°C. The yield of cells was only 21.3% of that obtained by 
Yamanaka (see Table 6). 
Subsequently, a 10 L culture was prepared which yielded 
75 mL of washed bacterial cells. A sample of this was dried 
but again the yield was poor, only 21.8% of that quoted by 
Yamanaka (Table 6). 
In an attempt to increase the yield it was decided to vary 
the culture conditions. Three 200 mL cultures were grown, 
designated A, 8 and C. For batches A and 8, the culture 
medium was prepared in tap water. 8atch A was continuously 
mixed during culture and batch 8 was a static culture. 
8atch C was grown in a static culture and the media was made 
up in distilled water. It was thought that continuous 
mixing (batch A) might aid oxygenation of the cells, thereby 
encouraging growth. The use of tap water (batches A and 8) 
might possibly increase the concentration of minerals in the 
culture medium, again encouraging cell growth. All 3 
batches of media had a pH of 7.1. 
Table 6 - Yield of bacterial cells obtained after culture of Leuconostoc mesenteroides 
by Yamanaka"s technique 
VOL OF CULTURE DRY WEIGHT OF WEIGHT OF CELLS g/L % OF YIELD QUOTED 
WASHED CELLS OF CULTURE MEDIUM BY YAMANAKA 
2 Litres 0.8 g 0.4 21.3 
10 Litres 4.1 g o .41 21.8 
I 
00 
f-' 
I 
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Despite the varied conditions, there was no significant 
difference in the yields obtained. All 3 yields were still 
much lower than those of Yamanaka (Table 7). 
Although the bacteria did not grow as well as expected, it 
was decided to proceed with cell disruption and enzyme 
purification according to the method of Yamanaka (see 
Methods section). The cells were disrupted by grinding with 
levigated alumina. The crude extract was centrifuged and 
the supernatant was assayed for protein concentration, 
(Folin and Lowry method - see Methods section), and MDH 
activity (see Methods section). 
Enzyme activity present in the crude extract was at a much 
lower level than expected. The cell debris from the 
grinding procedure was examined microscopically and found to 
contain large numbers of bacterial cells which were still 
intact. The debris was reground with extra alumina and then 
taken through the purification procedure, with a small 
aliquot put aside 
From Table 8, it 
activity was lost 
at each stage for protein and MDH levels. 
can be seen that virtually all enzyme 
during the purification procedure, mainly 
during the first ammonium sulphate precipitation. 
It was evident from these results that the yield of 
bacterial cells was lower than expected, cell disruption by 
grinding with levigated alumina was unreliable and the 
purification procedure was difficult especially with small 
quantities of cells. 
Table 7 - Yield of bacterial cells obtained after varying culture conditions 
DRY WEIGHT OF 
WASHED CELLS 
WEIGHT OF CELLS g/L 
OF CULTURE MEDIUM 
---------- -----------------------------------------------
Batch A 0.119 g 0.595 
Batch B o . 122 0.61 
Batch C o . 126 0.63 
% OF YIELD QUOTED 
BY YAMANAKA 
31 .6 
32.4 
33.5 
I 
--- -----------------------' 
I 
CD 
W 
I 
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Table 8 - Protein and MDH yields from the first batch of 
Leuconostoc mesenteroides (purification by Yamanaka's 
method; cell disruption by grinding) 
I--STA~E OF PURIFICATION 
Crude extract after 
fir st grinding 
Crude extract after 
second grinding 
Ammonium sulphate 
fraction 1 
Ammonium sulphate 
fraction 11 
First crystals 
TOTAL PROTEIN 
mg/lOO mL 
527 
78 
20 
2 
MDH ACTIVITY 
u"jL 
192 
22 ,388 
23 
19 
13 
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Investigation of alternative cellular disruption technigues 
In an attempt to increase the efficiency of cellular 
disruption, three different disruption methods were 
compared. The 3 methods employed were: grinding with 
levigated alumina, ultrasonicating the cell paste, and using 
a Mickle cell disintegrator (bead mill). 
Using the ultrasonic probe involved putting 2 mL of cell 
paste into a small beaker surrounded by crushed ice. The 
probe was positioned in the beaker and switched on for one 
minute, after which the sample was left for one minute to 
cool. This procedure could be repeated as many times as 
required. 
The cell disintegrator involved mixing 2 mL of cell paste 
with an equal volume of fine glass beads. The mixture was 
then shaken for one minute by the disintegrator and then 
allowed to cool for one minute in crushed ice. The 
procedure could be repeated as required. 
From Table 9 it can be seen that 5 minutes of 
ultrasonification is the most efficient method of cellular 
disruption. The slightly lower activity yielded after ten 
minutes of ultrasonification may be due to denaturation of 
the enzyme by heat produced by the probe. 
Table 9 - Comparison of protein and MDH levels obtained in crude cell extracts after 
different methods of disruption 
METHOD OF DISRUPTION TIME OF DISRUPTION PROTEIN mg/lOO mL MOH ACTIVITY ulL 
Gr i ndi ng with 527 22,388 
alumina x 2 
Ultrasonic 1 minute 465 6,556 
probe 
Ultrasonic 2 minutes 668 6,808 
probe 
Ultrasonic 3 minutes 966 21,825 
probe 
Ultrasonic 4 minutes 1 ,401 56,429 
probe 
Ultrasonic 5 minutes 1,549 62,410 
probe 
Ultrasonic 10 minutes 61,957 
probe 
Cell 5 minutes 276 3,393 
disintegrator 
Cell 10 minutes 422 4,710 
disintegrator 
I 
00 
0'> 
I 
Assessment of 
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commercially produced Leuconostoc 
mesenteroides 
T',-JO c omme rei all "f produc~d ba.tches of 
mesentsroides ATCC 9135 assessed 
concentration and enzyme aCLivity. Both were small volume 
cultures grown in a LH500 fermenter. The batch designated 
'LMM' was grown in the medium suggest.ed by Yamanaka. The 
batch designated 'BH1' was grown in a brain heart infusion 
with 1% glucose added. Table 10 shows the protein and 
enzyme levels obtained from the crude extracts following 
ultrasonification of the cell pastes for 5 minutes. Much 
higher specific enzyme activity was obtained from the batch 
grown 
total 
in the brain heart infusion medium. Although the 
yield of cells from this was 
activity was more than 3 times higher, 
compared with 30.9 U/g of cells from 
Yamanaka's medium (Table 11). 
lower, the enzyme 
108.2 U/g of cells 
the batch grown in 
As the commercially produced batches gave 
yields than those batohes grown at Derby 
much higher cell 
(Tables 6 and 7), 
it was decided to discontinue inhouse culturing. Instead, 
MOH was extracted from the Leuconostoc mesenteroides 
produced commercially using brain heart infusion medium with 
1% added glucose. 
Table 10 - Protein and enzyme levels obtained from crude cell extract in two commercially 
produced batches of ~euconostoc mesenteroides 
r-------------------------------
Culture batch - BHl 
Culture batch - LMM 
WEIGHT OF CELLS 
g/L OF MEDIUM 
1.83 
6.92 
TOTAL PROTEIN 
mg/100 mL 
1,985 
2,027 
MDH ACTIVITY 
U/g 
47,460 
22,688 
SPECIFIC ACTIVITY 
U/mg PROTEIN 
2.39 
1.12 
I 
(» 
(» 
I 
Table 11 - Comparison of protein and enzyme yields with regard to media volume and 
cell growth 
WEIGHT OF CELLS mg PROTEIN/ mg PROTEIN/ MDH ACTIVITY 
g/L OF MEDIUM mL MEDIA 9 OF CELLS u/mL MEDIA 
Culture batch - BH1 1.83 0.083 45.09 0.198 
Culture batch - LMM 6.92 0.200 28.84 0.214 
MDH ACTIVITY 
U/g OF CELLS 
I (Xl 
'" I 
108.2 
30.9 
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Adoption of a column technique for enzyme purification 
The crude enzyme extract obtained after ultrasonification of 
t.he CE-ll past.e from the commercial culture batch, 'BHl i was 
pu~ified according ~o the meLhod of Yamanak5 (see Methods 
section), As was the case with the pilot batch (Table 8), 
most of the enzyme activity was lost at. t.he first ammonium 
sulphate precipitation stage. Since the technique was also 
cumbersome and time consuming, it was evident that an 
alternative means of purifying and concentrating the enzyme 
was required. 
Structurally, the MDH obtained from Leuconostoc 
mesenteroides is thought to be very similar to that obtained 
from Lactobacillus brevis, (26). Purification of MDH from 
Lactobacillus brevis using column chromatography has been 
described by Blomquist et al (see Methods section), so an 
attempt was made to adopt this technique to extract the 
enzyme from Leuconostoc mesenteroides. 
In the first stage, MDH is absorbed by passing the extract 
down a DE23 column. The enzyme is then eluted using a 
linear salt gradient prepared from phosphate buffer with 
increasing amounts of potassium chloride added. 
After carrying out this first st.age however, assay of the 
fractions eluted from the column showed no evidence of any 
enzyme activity (Table 12), although significant amounts of 
protein were present. Possible causes for the loss of 
activity were thought to be enzyme inhibition or loss of 
- 91 -
cofactors. To investigate this, zinc and magnesium ions 
(common enzyme activators) and EDTA (a met.al chelator and 
inhibitor) were added to the crud~ e>:tract. This shovJed 
(Table 13) that the presence of magnesium ions had no 
significant effect on enzyme a~tivity bUL chat zinc ions and 
EDTA were both powerful inhibitors. 
EDTA was present in the phosphate buffer described by 
Blomquist et al to elute the enzyme from the column and 
obviously did not inhibit the MDH extracted from 
Lactobacillus brevis. 
When the first column purification procedure was repeated, 
using buffer without EDTA to elute the enzyme, a significant 
amount of MDH activity was retained and the specific 
activity of the extract was increased (Table 12). 
At this pOint, purification of the enzyme was taken over by 
Port on Products Limited, using a development of the column 
techniques described by Blomquist et al. Pure enzyme was 
supplied in aliquots stored frozen at -20°C which were 
stable for several months. 
Table 12 - Protein and MDH activity levels obtained during first column stages of 
purification, as described by Blomquist et al 
TOTAL PROTEIN MDH ACTIVITY SPECIFIC ACTIVITY SPECIFIC ACTIVITY 
mgjlOO mL U/L U/mg PROTEIN QUOTED BY BLOMQUIST 
U/mg* 
---
Crude ext ract 1 ,401 56,429 4.03 2.00 
1st column eluate 85 20.00 
(phosphate buffer 
with EDTA) 
1st column eluate 89 31,327 35.2 
(phosphate buffer 
with EDTA) 
-------------- ---------
• - The assay of MDH activity by Blomquist et al is described in the Methods section. Since 
the reaction was carried out under different conditions, the specific activity levels are not 
directly comparable to those obtained in this study. They are included only to illustrate 
that a comparable percentage increase in activity was obtained in this work. 
I 
'" 
'" I 
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Table 13 - Comparison of MDH activity obtained from crude 
cell extracts when cofactors or EDTA is added to reaction 
mixture. 
Crude extract only 
Crude extract plus 
2 mmol/L zinc ions 
Crude extract plus 
2 mmol/L magnesium ions 
Crude extract plus 
2 mmol/L EDTA 
MDH ACTIVITY U/L 
56,429 
6,638 
54,262 
97 
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3.2. Development of a kinetic assay for mannitol 
The 
had 
production of a pure supply of mannitol dehydrogenase 
the quantity of enzyme now been assured, although 
available was only small. It was therefore possible to 
It was hoped begin 
that 
the development of 
the kinetic serum 
a mannitol 
mannitol 
assay. 
method, described by 
Blomquist et al (see Methods section) could be adapted for 
the measurement of urine samples and a linear range of 
approximately 0-20 mmol/L achieved. 
An initial experiment was carried out in which a series of 
aqueous mannitol standards over 
were analysed using the method 
the range 
of Blomquist 
0-1,000 mmol/L 
et al. The 
enzyme preparation was assayed using the protocol for 
assessing MDH activity (see Methods section) and was found 
to have an activity level of approximately 40 units/mL. The 
working reagent solution for the mannitol assay was prepared 
with an enzyme concentration of 1 unit/mL, a sufficient 
concentration to give detectable absorbance changes. 
However, when the mannitol assay was carried out, no 
absorbance changes occurred, even after an extended 
incubation period. The main difference between the MDH 
activity and the mannitol assays of Blomquist was the buffer 
employed. It was considered that the apparent lack of 
enzyme activity in the mannitol assay might be due to this. 
The initial experiment was repeated, using the protocol for 
the serum mannitol assay but substituting 50 mmol/L tris 
buffer at pH 8.6 for the 0.12 mol/L bicine buffer at pH 9.0. 
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Using this format, the absorbance readings did increase 
(Figure 7), thus confirming the idea that the enzyme 
preparation in use was either inhibited by the buffer bicine 
or was inactive at pH 9.0. The experiment was again 
repeated, this time using 0.12 mol/L bicine buffer at pH 
8.6. No absorbance changes were detected, indicating that 
the enzyme. It the bicine was causing the inactivation of 
was evident that substantial modification was necessary to 
obtain a reliable assay that was sensitive enough to give 
accurate measurements in the range 0-20 mmol/L. 
The working reagent solution containing NAD and enzyme, had 
been prepared 30 minutes prior to carrying out the assay and 
absorbance readings taken every 5 minutes at 340 nm. During 
this time, no significant absorbance changes were detected, 
indicating that there was no non- specific NAD reductase 
activity in the enzyme preparation. Subsequently the 
reagent was prepared immediately prior to use. 
To make examination of different aspects of the assay 
simpler and to conserve the limited supply of MDH, it was 
decided to the protocol of Blomquist et al 
extensively. 
change 
The coenzyme NAD and the enzyme MDH were 
up in 50 mmol/L prepared as separate 
tris buffer at pH 8.0. 
reagents, both made 
The concentration of NAD reagent was 
10 mmol/L, this concentration being used in the MDH activity 
assay. The MDH reagent was prepared at a concentration of 
1 unit/mL. The total reaction mixture volume was reduced 
from 3 mL to 1 mL, this being the minimum volume required 
Figure 7 - Assessment. of .MDH <J,.div'tj using tris buffer 
- the absorbance readings obtained from a 1 mol/L mannitol solution 
0.6 
0.5 
0.4 
I 
'" a-0.3 I El 
C 
0 
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'" OJ 0.2 
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for accurate readings in the spectrophotometer. 0.5 mL 
enzyme reagent was added to 0.4 mL coenzyme reagent. After 
mixing! D.! mL sample w=e added and absorbance readings 
commenced. Using this pro~ocoll the final reaction mixture 
had increased concen~rations of both NAD and MDH; 4 pmol/mL 
HAD and 0.5 units/mL MDH as opposed to 1.16 \lmol/mL and 
0.32 units/mL MDH in the Blomquist protocol. In addition to 
these changes, the reaction temperature was increased from 
25°C to 37°C to speed up the reaction and help increase 
absorbance changes. 
An experiment was carried out in which a series of aqueous 
manni tol, standards over the range 0-25 mmol/L were a'ssayed 
using the new method format. It can be seen (Figure 8) that 
the revised reagents and assay protocol gave much greater 
sensitivity and that although the absorbance changes were 
small, it was possible to produce a standard curve over the 
range 0-25 mmol/L mannitol. 
Adapt ion of the kinetic mannitol assay to the Cobas Bio 
centrifugal analyser 
It was decided to adapt the kinetic assay to run on the 
Cobas Bio analyser. This would allow further reduction in 
reagent consumption, greater precision of timing and 
measurement of smaller absorbance changes. 
The initial protocol for the automated procedure was kept as 
close as possible to that previously used but some 
modifications were unavoidable due to the limitations of the 
analyser. 
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Figure 8 - Standard curve for kinetic mannitol assay using 
reformulated reagents 
• 
• 
5 10 15 20 
Mannitol mmol/L 
• 
25 
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The smaller cuvette volume of the Cobas Bio allowed the 
total reaction mixture volume to be reduced to 100 ~L. The 
NAD concentration of the coenzyme reagent was maintained at 
10 mmol/L while the enzyme reagent concentration was 
increased to 3.5 units/mL, so that a proportionately smaller 
volume could be added. 
The assay began by the mixing of 40 ~L of coenzyme reagent 
with 10 ~L sample and 20 ~L distilled water (probe rinse) in 
the reaction cuvette. This was followed by the addition of 
15 ~L enzyme reagent (start reagent) and 20 ~L distilled 
water (probe rinse). Absorbance readings were then taken 
every 10 seconds (Table 14). 
This protocol gave a total reagent volume of 105 ~L, but the 
concentrations of enzyme and coenzyme in the cuvette 
reaction mixture were maintained at the same levels as in 
the previous manual assay. 
A series of aqueous mannitol standar.ds over the range 
0-10 mmol/L were assayed using this automated method. It 
can be seen (Figure 9) that the standard curve was not 
linear and the absorbance changes were small. 
Because of the arrangement of the optical light path on the 
Cobas Bio analyser, the absorbance change observed is not 
proportional to the total reaction mixture volume (see 
manufacturer's literature, Cobas BiD, Roche Products 
Limited). This characteristic enables the measured 
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Table 14 - Cobas Bio parameters for a kinetic mannitol assay 
(ALPHA) + MANNITOL 
1 Units mmol/L 
2 Calculation factor 1 
3 Standard 1 0 
4 Standard 2 0 
5 Standard 3 0 
6 Limit 0 
7 Temperature ( 0 C ) 37.0 
8 Type of analysis 3 
9 Wavelength (nm) 340 
10 Sample volume (ilL) 10 
11 Diluent volume (ilL) 20 
12 Reagent volume ( >I L ) 40 
13 Incubation time (sec) 30 
14 Start reagent volume ( ilL ) 15 
15 Time of fir-st reading ( sec) 10.0 
16 Time interval (sec) 10 
17 Number of r-eadings 30 
18 Blanking mode 1 
19 Printout mode 1 
NB Diluent volume refers to the sample probe rinse 
(distilled water). A further- 20 ilL distilled water is 
dispensed into the cuvette (not listed) . Reagent volume 
refers to the volume of coenzyme (NAD) r-eagent. 
r-eagent volume refers to the MDH enzyme reagent. 
Start 
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Figure 9 - Demonstration of increased absorbance changes when using 
double volumes of sample and reagent on the Cobas Bio analyser 
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absorbance change to be increased by using a larger reaction 
volume. On this basis, it was decided to double the sample 
and reagent volumes for the assay, (Table 15). Although 
this increased reagent consumption, the total reaction 
volume was still only 170 ~L, a considerable economy on the 
manual assay. 
It can be seen (Figure 9) that 
volume did indeed have the 
the larger reaction mixture 
effect of giving larger 
absorbance changes but the linearity was not improved. 
Optimisation of MDH conce12.!:Eatio_r: .. _~_r:._ the kinetic assay 
It can be seen from Figure 9 that the assay is not entirely 
linear. It was decided to investigate the concentration of 
MDH in the reagent in the hope that by optimising this, the 
linearity of the method might be improved. 
The MDH reagent was prepared at 5 different concentrations 
ranging from 1.0 unit/mL to 3.5 units/mL, the concentration 
presently used. Using these different reagents, a range of 
aqueous mannitol standards over the range 0-10 mmol/L were 
assayed. 
From this experiment, it was found that as the concentration 
of enzyme in the reagent increased, the rate of change of 
absorbance increased (Figure 10). However, as the rate of 
change of absorbance increased, the linearity of the method 
deteriorated such that at a concentration of 10 mmol/L 
mannitol, only the lowest enzyme concentration, 1 unit/mL, 
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Table 15 - Revised programme parameters for the kinetic 
mannitol assay on the Cobas Bio 
(ALPHA) + MANNITOL 
1 Units mmol/L 
2 Calculation fact.or 0 
3 Standard 1 2.0 
4 Standard 2 4.0 
5 Standard 3 6.0 
6 L imi t 10 
7 Temperature ( 0 C ) 37.0 
8 Type of analysis 3 
9 Wavelength (nm) 340 
10 Sample ().IL) 20 
11 Di luent volume ().IL) 20 
12 Reagent volume ( ).IL ) 80 
13 Incubation time (sec) 60 
14 Start reagent volume ( ).IL ) 30 
15 Time of fir st reading ( sec) 0.5 
16 Time interval (sec) 20 
17 Number of readings 10 
18 Blanking mode 1 
19 Printout mode 1 
NB Diluent volume refers to the sample probe rinse 
(distilled water). A further 20 ).IL distilled water is 
dispensed into the cuvette (not listed). Reagent volume 
refers to the volume of buffer-NAD reagent. Start reagent 
volume refers to the MDH reagent. 
. 
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Figure 10 - The effect of MDH concentration on linearity 
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gave over 90% of the predicted value (Table 16). It was 
evident that in order to improve the linearity of the assay, 
the smaller absorbance readings from the lower enzyme 
concentrations would have to be accepted. On an analyser 
such as the Cobas Bio or a similar instrument, reliable 
measurement of small absorbance readings is 
acceptable precision can be obtained. However, 
possible and 
if the assay 
was to be carried out manually, such small 
changes would be difficult to measure accurately. 
absorbance 
It was nevertheless decided to adopt the lowest enzyme 
concentration used, 1.0 unit/mL reagent 
acceptable linearity. 
in order to gain 
Optimisation of NAD concentration for the kinetic assay 
The coenzyme NAD is necessary for the conversion of mannitol 
to fructose by MDH. If the quantity of NAD in the reaction 
mixture is insufficient, then this will limit the reaction 
rate, especially at high concentrations of mannitol. The 
optimum concentration of NAD is therefore one at which NAD 
is present in slight excess so that the addition of extra 
NAD does not increase the reaction rate. In view of the 
small absorbance changes obtained, it was decided to 
investigate the effect of NAD concentration on the assay to 
see if the reaction rate could be increased. 
Using the Cobas Bio analyser, a 10 mmol/L aqueous mannitol 
solution was assayed. The formulation of the NAD reagent 
used was varied so that the final concentration of NAD in 
Table 16 - Optimisation of enzyme concentration - the effect on linearity 
MANNITOL 2 mmol/L 4 mmol/L 6 mmol/L 8 mmol/L 
CONC 
ENZYME CONC PERCENTAGE OF PREDI CTED VALUE OBTAINED 
OF RGT UNITS/mL 
3.5 100 96.7 93.3 89.4 
2.5 100 96.9 92.7 91.4 
1.90 100 98.0 92.0 92.0 
1 . 29 100 97.1 9 6 . 1 92.6 
1.00 100 96.2 100 96.2 
NB - Predicted value = Absorbance/minute for the 2 mmol/L standard x __ ~2~~7 
(mannitol) 
% of predicted value = Absorban~Lminute_obtained x 100 
Absorbance/minute predicted 
10 mmol/L 
87.61 
I 
I 
,... 
89.4 0 
'" I I 88.8 
89.4 
92.3 
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the reaction mixture ranged from 0-10 mmol/L. 
It can be seen (Figure 11) that the absorbance changes 
observed increased as the NAD concentration increased. It 
had been expected that a final reaction mixture 
concentration of 10 mmol/L NAD would be sufficient to give 
an excess of NAD. It appeared however that this was not the 
case, the slope of the curve in Figure 11 indicating that 
the reaction rate could be increased by NAD concentrations 
of greater than 10 mmol/L. 
The NAD reagent 
10 mmol/L had 
which gave a final cuvette concentration of 
a reagent concentration of 52.5 mmol/ L , in 
order to allow for its dilution by the sample and enzyme 
reagent. It had been found when preparing this solution 
that it was extremely difficult to dissolve the NAO. It was 
therefore decided that it would be impractical to increase 
the concentration of NAD further to try and achieve an 
excess level. Instead, the concentration of 52.5 mmol/L was 
taken as the optimum and used in subsequent assays. 
Investigation of pH optimum for MDH activity 
The stated pH optimum for MDH activity is pH 8.6 (25, 26). 
An investigation was carried out to confirm this pH optimum 
and establish how sensitive the enzyme was to pH variation 
under the reaction conditions employed. 
Using the Cobas Bio analyser, a 10 mmol/L aqueous mannitol 
solution was assayed. The NAD and MOH reagents were 
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Figure 11 - Optimisation of NAD concentration in the-reaction cuvette 
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prepared in buffers with different pH values over the range 
pH 8.0-9.0. 
MDH showed no activity at all when prepared in buffers at pH 
8.0, 8.2 and 8.4. Between pH 8.5 and 9.0, there were 
varying levels of activity, with a narrow optimum pH range 
of 8.6 to 8.8 (Figure 12). 
Assessment of precision of the automated kinet~c assay 
Using the Cobas Bio analyser, a precision check was carried 
out for the kinetic assay. Within batch precision was 
assessed by analysing 20 duplicates at 1 and 5 mmol/L 
mannitol. Between batch precision was assessed from the 
results of 2 urine samples stored frozen in aliquots and 
analysed in 6 separate batches. 
Within batch results showed coefficients of variation (CVs) 
of 2.88% and 1.95%. Between batch precision was found to be 
10.53% and 10.72% (Table 17). 
Recovery of urinary mannitol by kinetic assay 
In order to give a preliminary assessment of recovery of 
urinary mannitol, 6 urines containing varying amounts of 
mannitol were spiked with an additional 3 mmol/L mannitol. 
The spiked and unspiked samples were analysed and the 
difference between the 2 results taken as a measure of the 
percentage recovery. 
Figure 12 - Investigation of reaction pH and MDH activity 
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Table 17 - Precision data for the kinetic mannitol assay 
(using the Cobas Bio analyser) 
MEAN MMOL/L SD MMOL/L CV % 
Wi thi n batch 1.04 ±0.03 2.88 
n = 20 4.37 :: 0 . 09 1 .95 
Between batch 1 .05 = 0.11 10.53 
n = 6 4.42 ~ 0.47 10.72 
I 
f-' 
f-' 
f-' 
I 
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The recoveries ranged from 57% to 92% with a mean of 73.5%. 
This was lower than expected and clearly unacceptable. 
In order to investigate the poor urine recovery levels, 
mannitol was added to a commercial urine control, designated 
ECS, to give a series of solutions over the range 
0-10 mmol/L. These solutions were assayed and compared to a 
series of aqueous mannitol standards over the same range. 
It can be seen (Figure 13) that there is a significant 
difference in the response of the urine based solutions to 
the aqueous standards. 
It was demonstrated previously that the enzyme MDH had a 
narrow pH operating range. The poor and variable recoveries 
might be due to failure of the buffer to adequately maintain 
the reaction pH at 8.6 when urines were being analysed. 
An investigation of the performance of several different 
buffers was carried out. This included the presently used 
0.05 mol/L tris buffer and various other concentrations of 
tris and other buffers. Each buffer was prepared with an 
initial pH of 8.6. 1 mL of each buffer was added to 0.5 mL 
of each urine and the resulting pH measured. Ten 5 hour 
urines and 5 early morning urine specimens were used. 
It can be seen (Table 18) that for the 5 hour urine 
specimens, the 2 mol/L glycine, 0.4 mol/L glycine/hydrazine 
and the 0.5 mol/L tris buffers were all able to maintain a 
pH of 8.5-8.6. However, for the more concentrated early 
...1 10 
"-
..... 
0 
~ 
" 0 8 .... 
...., 
'" r.. ....,
" QJ 
U 
" 6 0 
u 
..... 
0 
...., 
.... 
" 
" 
'" 
4 8 
u 
QJ 
r.. 
::l 
'" 
'" QJ 2 ;:;: 
-113-
Figure 13 - Comparison of results of an aqueous and urine 
based standard curve 
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Table 18 - Comparison of different buffers performance for maintaining ur ine pH 
--_ .•... _--
BUFFERS (SEE BELOW) 
1 2 3 4 5 6 7 8 
5 H URINE 
SPECIMEN 
1 5.26 8.44 8.55 8.58 8.42 8.53 8.60 
2 6.32 8.58 8.60 8.60 8.45 8.55 8.63 
3 5.77 8.07 8.43 8.57 8.44 8.50 8.62 
4 5.77 8.53 8.57 8.61 8.45 8.54 8.62 
5 6.16 8.58 8.60 8.59 8.42 8.55 8.62 
6 5.43 8.44 8.54 8.61 8.55 8.53 8.60 
7 5.58 8.37 8.52 8.56 8.50 8.52 8.62 
8 9.19 8.67 8.63 8.63 8.49 8.49 8.63 
9 5.99 8.54 8.58 8.59 8.70 8.54 8.63 
~O 5.58 8.28 8.48 8.52 8.58 8.55 8.63 
EARLY MORNING 
SPECIMEN 
1 5.05 7.81 8.20 8.33 8.34 7.91 8.59 8.63 
2 5.71 7.23 8 . 11 8.28 8.37 8.32 8.52 8.59 
3 6.63 8.52 8.39 8.50 8.44 8.49 8.36 8.53 
4 5.66 8.37 8.41 8.46 8.43 8.47 8.55 8.62 
5 5.52 7.90 8.24 8.38 8.36 8.01 8.47 8.59 
Buffers 
1 Initial urine pH 
2 Glycine buffer 0.4 mol/L 
3 Glycine buffer 1 mo1/L 
4 Glycine buffer 2 mol/L 
5 Glycine/hydrazine buffer 0.4 mol/L 
6 Tris buffer 0.05 mol/L 
7 Tr is buffer 0.25 mol/L 
8 Tris buffer 0.5 mol/L 
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morning urine specimens, the 0.5 mol/L tris buffer was the 
only buffer which had sufficient capacity to maintain the 
correct pH. 
It was therefore concluded that the 0.5 mol/L tris buffer 
should be used for the assay of mannitol using MDH. This 
should ensure that the reaction mixture is maintained at pH 
8.6 and the MDH activity is at its maximum. 
Recovery of urinary mannitol by kinetic assay 
In order to assess the recovery of mannitol in urine by this 
method, 21 urine specimens containing varying amounts of 
mannitol (between 0.0-5.0 mmol/L mannitol approximately) 
were spiked with an additional 3 mmol/L mannitol. The 
spiked and un spiked urines were both analysed and the 
difference between the two results was taken as a measure of 
the percentage recovery. 
The recoveries ranged between 31 and 95%, with a mean of 
75.7% (Table 19). The low mean and wide range of recoveries 
was clearly still unacceptable. 
Experiment to improve urinary mannitol recoveries by use of 
desalting resin and activated charcoal 
A possible cause for the low urine recoveries was thought to 
be the presence of interfering substances or an enzyme 
inhibitor in the urine matrix. The effect of pretreating 
urine samples with an absorbant resin or activated charcoal 
in order to prevent this interference was investigated. 
-116-
Table 19 - Assessment of recovery of urinary mannitol using the kinetic mannitol assay 
------_ .. _ ... -
MANNITOL OBTAINED IN MANNITOL OBTAINED IN SPIKED-ORIGINAL % RECOVERY 
ORIGINAL SAMPLE mmol/L SPIKED SAMPLE mmoll L mmol/L 
1 1 .49 3.97 2.48 83 
2 4.31 6.59 2.28 76 
3 1 . 11 3 .41 2.30 . 77 
4 2.51 5.10 2.29 76 
5 0.64 . 3.20 2.56 85 
6 2.38 4.64 2.26 75 
7 0.78 3.24 2.46 82 
8 5.80 7.99 2.19 73 
9 1.48 3.58 2.10 70 
10 0.78 3 .16 2.46 82 
11 3.78 5.80 2.02 G7 
12 0.08 2.40 2.32 77 
13 0.77 3.24 2.47 82 
14 6.40 8.35 1.95 65 
15 0.02 2.50 2.48 83 
16 1 .27 3.37 2.10 70 
17 2.97 3.90 0.93 31 
18 0.08 2.93 2.85 95 
19 0.11 2.45 2.34 .78 
20 0.08 2.60 2.52 84 
21 0.11 2.48 2.37 79 
----
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Nine of the spiked and unspiked samples were analysed to 
obtain recovery values. I mL aliquots of both spiked and 
unspi}:~d urin2S we~~ ~red~ed WiLh Amberli~e monobed resin by 
adding resin to about 'litJCI -t hir-ds of th~ aliquot volume, 
mixing thoroughly and then centrifuging for 5 minutes at 
2,000 g. ?queous standards for ~he assay were ~reated 
5 imi lady. The supernatants were then analysed, using the 
pretreated standards, to obtain recovery values. Further 
aliquots of spiked and unspiked samples were pretreated in 
the same way using activated charcoal instead of resin. 
These were also analysed, 
obtain recovery values. 
using pretreated standards to 
A comparison of the values obtained (Table 20) shows that 
mean recovery of mannitol was increased by the use of both 
Amberlite resin and activated charcoal. However, there was 
still significant variation in the recoveries, particularly 
when using charcoal. Although pretreatment increases 
recovery, the method is cumbersome and not completely 
satisfactory. 
E:xnerirnent to improve urinary mannitol recoveries by use of 
urine based standards 
Pretreating urines with absorbants to minimise interference 
had already been shown to give some improvement in recovery. 
However, this extra step was time consuming and cumbersome 
so an alternative approach of using a urine based standard 
curve was considered. It was hoped that the use of urine 
based standards would produce a similar level of 
Table 20 - Comparison of the effects of absorbant resin and activated charcoal on the 
urinary recovery of mannitol 
MANNITOL RECOVERY MANNITOL RECOVERY MANNITOL RECOVERY 
(NO SAMPLE PREPARATION) (SAMPLES DESALTED (SAMPLES MIXED WITH 
WITH AMBERLITE RESIN) ACTIVATED CHARCOAL) 
1 76 82 44 
2 77 99 115 
3 76 98 79 
4 85 93 86 
5 75 100 112 
6 82 93 101 
7 73 92 112 
8 70 92 95 
9 67 84 69 
Mean 75.7% 92.3% 90.3% 
SO : 5.5% !"6.2% ~ 23.5 
'-' 
'-' 
ro 
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interference in both standards and. samples and lead to 
better recoveries. 
A commercially obtained urine control, designated ECS, was 
used to prepare a range of mannitol standards from 0-10 
mmol/L, These were assayed and compared with a series of 
aqueous standards over the same range, It can be seen 
(Figure 14), that the measured or 
aqueous standards was greater 
apparent mannitol in the 
than that of the urine 
standards, 
samples. 
confirming the low results obtained from urine 
A series of urine specimens containing mannitol were spiked 
with a further 3 mmol/L mannitol. Both the spiked and 
unspiked samples were analysed. Recovery values were 
calculated from mannitol levels derived from both aqueous 
and urine based standard curves. 
There was a significant improvement in recovery when the 
mannitol levels were calculated from the ECS urine standard 
curve, although the variability of 
unacceptably high (Table 21). 
recovery was still 
10 
8 
6 
4 
2 
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Figure 14 - Kinetic mannitol assay. Comparison of linearity of 
aqueous and urine based standards 
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Table 21 - Comparison of urinary mannitol recoveries 
obtained using aqueous and urine based standard curves 
MANNITOL RECOVERY MANNITOL RECOVERY 
READING FROM AQUEOUS READING FROM URINE 
STANDARDS (%) BASED STANDARDS (%) 
1 89 102 
2 83 94 
3 90 102 
4 87 99 
5 79 89 
6 76 86 
7 86 97 
8 81 92 
9 91 103 
10 87 99 
11 88 98 
12 89 101 
13 88 100 
14 80 91 
15 86 97 
16 88 101 
17 79 90 
18 78 88 
19 82 93 
20 77 88 
Mean 84.2% 95.5% 
SD ! 4 .8% : 5.5% 
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3.3. Development of an end point assay for mannitol 
The kinetiC enzyme assay developed has shown reasonable 
precision and acceptable linearity. However, the absorbance 
changes are very small and the recoveries lower and more 
variable than expected, despite the use of urine standards. 
As the assay utilises reaction rate as a measure of 
concentration, the amount of enzyme activity in the reagent 
is critical which limits the robustness of the assay. 
In view of these factors, it was decided to investigate the 
development of an end point assay. Lunn et al had recently 
published such a method (30) which was evaluated and found 
to be unacceptable. 
Initially, a series of aqueous mannitol standards over the 
range 0 to 10 mmol/L were analysed by the method of Lunn et 
al on the Cobas Bio analyser. Urine based standards 
covering the same range were prepared in ECS and analysed by 
the same method. 
Lunn et al had reported their method to be 'almost linear' 
over the range 0.34 to 5.49 mmol/L. This experiment showed 
no linear region in the standard curve in either aqueous or 
ECS solutions (Figure 15). This was confirmed in a 
subsequent experiment. A plot of the change in absorbance 
with time indicates that the reaction had not reached 
completion after 5 minutes (Figure 16). 
by this method, 17 urine specimens, 
7.5 mmol/L mannitol were spiked with 
To assess recovery 
containing 0.00 to 
a further 3 mmol/L 
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Figure 15 - End point mannitol assay as described by Lunn et al; 
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Figure 16 - End point mannitol assay as described by Lunn et alj 
the time course of the reaction for a 6 mmol/L aqueous mannitol soln 
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mannitol. The spiked and unspiked urines were analysed and 
the difference of the two results was taken as a measure of 
the recovery of the added mannitol. The recoveries ranged 
from 69.3% to 91%, with a mean of 79.7%. These levels were 
comparable to those obtained by the kinetic assay, but were 
still unacceptable. 
The end point assay has the advantage of large absorbance 
changes and uses less NAO than the kinetic method. Both 
methods gave relatively poor recoveries. However, the end 
point method uses over 5 times more MOH than the kinetic, 
does not reach completion after 5 minutes and is non linear. 
Change in temperature of the assay 
Lunn et al had carried out the mannitol assay at 40·C. This 
temperature was chosen to decrease the time for the reaction 
to reach completion. Most laboratory analysers and 
spectrophotometers do not have the facility to operate at 
this temperature. Therefore, in order to produce a widely 
applicable method, it was considered that a reaction 
temperature of 37·C would be more suitable although this 
would lead to a longer incubation time. All subsequent 
• experiments were carried out at 37 C. 
Lunn et al had reported that the assay was subject to 
product inhibition by fructose. Given the high Michaelis 
constant of mannitol, it was considered possible that the 
poor linearity and failure to reach end point of the 
reaction may be due to high fructose concentrations in the 
-126-
reaction mixture. 
To assess this phenomenon, two experiments were devised 
using a 12 mmol/L aqueous mannitol solution. Firstly the 
volume of reagent (buffer containing NAD) was doubled. This 
increased the reaction volume so diluting the fructose 
formed and perhaps reducing fructose inhibition. Since the 
format of the reagent was unchanged, the amount of NAD 
present in the cuvette was twice that previously employed. 
In the second experiment, the volume of reagent was doubled 
but its concentration of NAD was halved, thereby maintaining 
the amount of NAD in the cuvette at its original amount. 
It can be seen from the second experiment (Figure 17) that 
the increase in reaction volume in conjunction with the 
original quantity of NAD had no effect on the time taken for 
the reaction to reach completion. When the amount of NAD in 
the cuvette was doubled, the reaction appeared to have 
reached completion after 15 minutes (Figure 17). 
From these experiments, it was concluded that the reaction 
should be monitored for at least 15 minutes and the larger 
reagent volume, 80 ~L, should be used. The HAD 
concentration also needed to be optimised. 
Using 80 ~L of reagent at the original concentration of NAD, 
an experiment was carried out to investigate the effect of 
reducing the sample volume. It was hoped that this would 
reduce the time taken for the reaction to reach end point 
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Figure 17 - End point mannitol assay based on Lunn et al; 
the time course of the reaction with doubled reagent volumes 
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and improve the linearity while still giving absorbance 
changes. large enough to be easily measured. 
A series of aqueous mannitol standards over the range 0 to 
10 mmol/L were analysed using sample volumes of 5, 10 and 
20 plo The reaction was then monitored over a period of 10 
minutes. 
Using a sample volume of 5 pL, a significant improvement in 
linearity was demonstrated (Figure 18). The reaction 
reached a plateau after about 8 minutes whi le still giving 
an absorbance change of 0.07 absorbance units/mmol/L 
mannitol (Figure 19). 
The modifications made to the end point assay improved the 
linearity of the method and allowed it to achieve end point. 
Previously it had been shown that 0.5 mol/L tris-
hydrochloric acid was the most effective buffer for 
controlling the pH to 8.6, the optimum pH for MDH. It was 
decided at this stage to substitute 0.5 mol/L tris for the 
glycine-hydrazine buffer recommended by Lunn. A series of 
aqueous mannitol standards from 0 to 16 mmol/L were assayed 
and 17 urines containing mannitol were spiked with a further 
3 mmo1/L mannitol to obtain recovery values. 
Despite the superior pH control of the tris buffer, it can 
be seen that the assay still has poor linearity (Figure 20), 
and that the urinary recoveries are variable and low, Table 
22. 
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Figure 18 - Increased 11nearity with decreased sample volume in 
the end point mannitol assay 
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Figure 19 - The time course of the MDH reaction in the end pOint 
mannitol assay with different sample volumes 
.a---_a 5 ilL sample vol 
.'-~---.... 10 ilL sample vol 
>;10'-----.... " 20 ilL sample vol 
2 4 6 8 10 12 
Time. (minutes) 
Figure 20 - Linearity of end point assay after some modification 
12 
10 
8 
/ 
• 
...J l / I "- t-' ..... W 0 6 t-' ~ I 
..... 
0 
..., 
..... 
c 
c 4 ~ Cl! • 8 
'0 
Q) 
.. 
" (f) Cl! 
~ 2 
2 4 6 8 10 12 14 16 
Mannitol mmol/L 
Table 22 - Recovery of mannitol in urine using the modified end point method 
URINE URINE SPECIMENS 
CONTAINING MANNITOL 
URINE SPECIMENS 
SPIKED WITH ADDITIONAL 
3 mrnol/L MANNITOL 
% RECOVERY OF 
ADDED MANNITOL 
f-------------------------------------------
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
Mean = 
SD = '! 
3.30 
5.33 
4.10 
6.08 
3.74 
0.98 
2.68 
1 .33 
1.15 
3.55 
5.55 
1 .69 
0.08 
2.97 
7.64 
3.29 
4.06 
79.7% 
7.4% 
5.65 
7.58 
6.58 
8.21 
6.16 
3.66 
4.78 
3.99 
3.81 
5.61 
7.70 
4.34 
2.81 
5.32 
9.90 
5.66 
6.14 
78.3 
75.0 
82.7 
71.0 
80.7 
89.3 
70.0 
88.7 
88.7 
76.7 
71.7 
88.3 
91.0 
78.3 
75.3 
79.0 
69.3 
I 
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QRtimisation of enzyme concentration in reaction mixture 
In an attempt. to improve the linl2arit.y of the end point 
&'sso.y: LO find Lhe optimum 
conce-ntr&tion of Enzyme used. Lunn et a1 had uSEd MDH at b 
concentration of 5 U/mL r~agen~. Previously in this study, 
the MDH had been used az a concentration of 40 U/mL (it was 
supplied, ready to use, in buffer at this concentration). 
A series of aqueous mannitol standards from 0 to 16 mmol/L 
were assayed using enzyme concentrations of 10, 20 and 
40 U/mL. At 10 U/mL, it can be seen zhat the curve is 
linear up to mannitol concentrations of S mmol/L but there 
is little increase in absorbance levels above this (Figure 
21 ) . At 20 U/mL the curve is linear up to 
falls away slightly at levels above this. 
the standard curve appears to be'S' shaped. 
12 mmol/L but 
Using 40 U/mL, 
It WaS concluded from this experiment that the optimal 
enzyme concentration is about 20 U/mL, although even at this 
level, the standard curve is not completely linear. 
Investigati0I! of the effect of hexokinase and ATP on the MDH 
reaction 
Despite the modifications made to improve the linearity of 
the method, it was felt that it still needed to be improved. 
Product inhibition by fructose seemed the most likely cause 
of the pr obl em. Rather than trying to further dilute the 
reaction mixture, thereby losing sensitivity, it was decided 
to attempt the alternative approach of chemically removing 
Figure 21 - Optimisation of enzyme concentration for the end point mannitol assay 
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the fructose. This was to be done by adding hexokinase and 
ATP to the reaction mixture, thereby converting fructose to 
fructose-6-phosphate, ie: 
MANNTIDL + NAD MJH>NADH+FROCIOSE HEXOONASE ATP > FRUCTOSE-6-lIDSHlAlE + ADP 
In the assay, a sample volume of 5 ~L is diluted into a 
final reaction mixture volume of 130 ~L. Thus, a sample 
with a mannitol concentration of 15 mmol/L can give rise to 
a fructose concentration of 0.6 mmol/L in the cuvette. One 
unit of hexokinase can remove 1 ~mol/mL/minute fructose, 
therefore a minimum of 0.6 hexokinase units/assay are 
required. It was proposed to incorporate the hexokinase and 
ATP into the NAD/tris buffer reagent, of which 80 ~L/assay 
was used. By adding 100 units hexokinase into 5 mL of 
NAD/tris reagent, 1.0 units hexokinase/assay would be added, 
allowing an excess of enzyme_capacity. ATP was included in 
the NAD/tris buffer reagent at a concentration of 11 mmol/L 
(again allowing an excess over the amount needed). 
Mannitol was added to the urine control ECS, at 
concentrations over the range 0 to 12 mmol/L. This was 
analysed with and without the addition of hexokinase and ATP 
t.o t.he reagent.. A significant. improvement in the linearit.y 
of the assay was observed when hexokinase and ATP were added 
(Figure 22). 
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Figure 22 - Comparison of standard curves obtained with and without the addition of 
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Addition of magnesium ions to activate hexokinase 
Although the addition of hexokinase and ATP to the reaction 
mixture improved linearity, the addition of 100 units of 
hexokinase per 5 mL of 
should be necessary. 
reagent was well in excess of what 
Many commercial assay systems 
utilising hexokinase, contain magnesium ions at a 
concentration of approximately 5 mmol/L as an activator. It 
was therefore decided that uSing magnesium ions at this 
concentration (in the form of MgS04.7H20), it should be 
possible to use 50 units/5 mL hexokinase to overcome the 
problem of fructose interference. To investigate this, 
using an 8 mmol/L mannitol standard, two aqueous mannitol 
solutions with concentrations of 10 and 15 mmol/L were 
analysed. A third solution containing 10 mmol/L mannitol 
and 10 g/L fructose was also analysed. The 3 solutions were 
all measured using reagents containing hexokinase at 
concentrations of 0, 50 and 100 units/5 mL, with and without 
magnesium ions. 
It can be seen that at a mannitol concentration of 10 mmol/L 
recoveries of about 99% were obtained (Table 23). This 
level of recovery was still attained even in the presence of 
excess fructose when the reagent contained hexokinase, ATP 
and magnesium ions. It was concluded that a solution 
containing 50 units/5 mL hexokinase and 5 mmol/L magnesium 
ions was optimal. 
• 
Table 23 - The effectiveness of adding hexokinase to prevent inlerfel-ence by fructose 
._----_._-----_ .. _------.. _----_._---------_._--_._---------_._._-----_ .... _-_._._._ .. 
KNOWN CONC 
Of SOLN 
15 mmol/L 
mannitol 
10 mmol/L 
mannitol 
10 mmol/L 
mannitol t 
10 g/L fructose 
RGTS CONTAINING 5 mmol/L MAGNESIUM IONS 
NO HK 50 U HK/ 100 U HE/ 
IN RGT 5 mL RGT 5 mL RGT 
% RECOVERY % RECOVERY % RECOVERY 
92.3 94.4 94.0 
99.0 99.4 98.1 
82.5 101.0 100.8 
RGT CONTA HIl Ne; NO !'!)\GNES 1'.11'1 
NO HK 
IN RGT 
0, 
'0 RECOVERY 
92.9 
99 .1 
81.9 
50 U HE/ 
5 1nL RGT 
100 U HK/ 
5 mL RGT 
,,------_. __ .. _._- ------- ----
~,; RECOVERY "- RECOVERY '0 
93.0 93.3 
99.3 98.9 
81.3 81.7 
.--_ .. __ ._--..... _-------.j 
, 
.... 
w 
00 , 
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Optimisation of NAO concentration 
Up to this point, the concentration of NAO in the reagent 
was that suggested by Lunn et al, 10.9 mmol/L. Having 
achieved a linear assay, it now was decided to optimise 
this. 
The reagent presently used, 10.9 mmol/L, is equivalent to a 
final cuvette concentration of 6.7 mmol/L NAO. 
Using a sample mannitol concentration of 8 mmol/L, the 
amount of NAO in the reagent was varied to give a final 
reaction mixture concentration over the . range o to 
10 mmol/L. 
It can be seen (Figure 23) that the reaction rate increased 
up to an NAD concentration of 4.0 mmol/L. In order to 
ensure that NAD was still present in slight excess, it was 
decided to select an NAO concentration 6.0 mmol/L (final 
reaction mixture concentration) for use in the assay. This 
meant that when preparing the reagent, the amount of NAO 
added could be reduced from 10.9 mmol/L to 9.8 mmol/L. 
Investigation of stoichiometry and time course of the MOH 
reaction 
An experiment was carried out to determine whether 100% 
conversion of mannitol to fructose was being achieved at the 
end point. 
Solutions of mannitol in water and ECS were prepared at 
Figure 23 - Investigation of the effect of NAD concentration on reaction rate 
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concentrations of 5, 8 and 11 mmol/L. All 6 solutions were 
then assayed using an incubation time of 30 minutes. 
A plot of the time course of the reaction (Figure 24) for 
the 11 mmol/L aqueous sample showed that the reaction had 
reached completion after about 10 minutes. 
The absorbance changes (Table 24) showed that in both 
aqueous and urine samples, approximately 90% of the mannitol 
is converted to product. The reaction reached completion 
after about 10 minutes with no significant change in 
absorbance readings over the subsequent 20 minutes. 
NB - % conversion calculated from Absorbance change x Factor, 
where Factor = 1 x E 
1 x 
0.58 
final volume 
sample volume 
Investigation of optimum ~_~~~MD~acti~~ 
The use of tris-hydrochloric acid buffer at a concentration 
of 0.5 mol/L has been introduced because this was found to 
be the most effective means of buffering urine specimens to 
the stated optimum pH for MDH of 8.6 (see Results section 
3.2.) An experiment was carried out to determine the effect 
of pH on MDH activity over the range 8.0 to 9.0 with and 
without the addition of hexokinase, ATP and magnesium. 
Using a sample mannitol concentration of 12 mmol/L. reagent 
was assessed which had been made up in 0.5 mol/L tris buffer 
prepared over the pH range 8.0 to 9.0. 
1-0 
0·8 
0·6 
A340nm 
0·4 
0·2 
Figure 24 - Plot of time course of the reaction, showing 
completion after 10 minutes 
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Table 24 - Investigation of stoichiometry of MDH reaction 
,-------------------------------------_. __ .-
SPECIMEN 
5 mmo1/L (aqueous) 
5 mmo1/L (aqueous) 
5 mmo1/L (aqueous) 
8 mmo1/L (aqueous) 
8 mmo1/L (aqueous) 
8 mmo1/L (aqueous) 
11 mmo1/L (aqueous) 
11 mmo1/L (aqueous) 
11 mmo1/L (aqueous) 
5 mmo1/L (urine) 
5 mmo1/L (urine) 
5 mmo1/L (urine) 
8 mmo1/L (urine) 
8 mmo1/L (urine) 
8 mmo1/L (urine) 
11 mmo1/L (urine) 
11 mmo1/L (urine) 
11 mmo1/L (urine) 
INCUBATION 
TIME (MINS) 
10 
20 
30 
10 
20 
30 
10 
20 
30 
10 
20 
30 
10 
20 
30 
10 
20 
30 
ABSORBANCE CHANGE 
AT 340 NM 
0.5718 
0.5737 
0.5580 
0.8929 
0.9150 
0.8980 
1.2193 
1.2429 
1.2221 
0.5712 
0.5693 
0.5518 
0.8851 
0.9056 
0.8884 
1.2146 
1.2759 
1.2623 
CONVERSION Or 
MANNITOL TO rRUCTOSE 
90.7 
91.0 
88.5 
88.6 
90.1 
89.1 
88.0 
89.7 
88.2 
90.6 
90.4 
87.6 
87.8 
89.9 
88.1 
87.6 
92.1 
91.1 
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In the absence of hexokinase, the activity of MDH declined 
markedly outside the pH range 8.3 to 8.8, with an optimum pH 
at 8.6 to 8.8. In the presence of hexokinase, ATP and 
magnesium, there was a plateau of optimum activity over the 
pH range 8.0 to 8.8 (Figure 25). 
Change in reagent volumes and assessment of reagent 
stability 
In order to make the assay simpler and easily adaptable to 
other laboratory analysers, the formulation of the reagents 
was changed. Equal volumes of SO ~L for the coenzyme (NAD, 
ATP, magnesium and hexokinase) and the enzyme reagent (MDH). 
were used rather than 80~L for the coenzyme and 20 ~L for 
the enzyme reagent. The total volume of reaction mixture 
was unchanged, 
constituents. 
as was the concentration of all the 
The final formulation of reagents and parameters for both 
the automated assay (using a Cobas Bio) and an equivalent 
manual assay is listed in the Methods section. 
To assess the stability of the coenzyme reagent, aliquots of 
the working reagent were stored in sterile containers at 4·C 
for up to 4 weeks. A series of urine aliquots containing 
mannitol over the range 1-12 mmol/L were stored at -20·C. A 
specimen of each urine was thawed and analysed using the 
stored coenzyme aliquots each week for 4 weeks. 
No significant loss of reagent performance could be detected 
-145-
Figure 25 - Investigation of the effect of pH, 
with and without the addition of HK and ATP 
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25 ) . It was concluded that the 
coenzyme reagent could be prepaced in batches and used over 
a per iod of at. least. 4 we021:s wherl st.ored at 4 <'C. 
reagent vJas st.ored in aliquot.s and was stable 
Recovery of mannitol in urine 
The enzyme 
for several 
Recovery was assessed by adding mannitol to urine samples. 
The mannitol concentrations of the spiked and unspiked 
samples were measured by the automated or manual assays and 
percentage recoveries calculated. Four samples assessed by 
the manual assay over the range 1 to 11 mmol/L gave a mean 
recovery of 101.6% (range 98.4 to 108.1%). Twelve samples 
assessed by the automated assay over the range 1 to 
12 mmol/L gave a mean recovery of 
103.3%). 
100.1% (range 94.5 to 
Precision of optimised end point method 
Using the Cobas Bio analyser to carry out the optimised 
method, the within batch precision was assessed by analysing 
20 duplicates at 5 and 11 mmol/L mannitol. Between batch 
precision was assessed from the results of 2 urine samples 
stored frozen 
batches. 
in aliquots and analysed in 12 separate 
Within batch results showed a CV of less than 1% at both 
levels while the between batch results had CVs of less than 
4%, (Table 26). 
, 
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" 
Table 25 - Assessment of stability of coenzyme reagent 
INITIAL RESULTS WEEK 2 WEEK 3 WEEK 4 WEEK 5 
-, 
BLANK VALUE O,OB 0.06 0.06 0.05 0.05 
OF REAGENT~ 
ABSORBANCE FACTOR 9 .17 10.11 9.76 9.73 9.77 
OF REAGENT* 
- -----,-
MANNITOL MANNITOL MANN ITOL MANNITOL MANNITOL 
RECOVERY % RECOVERY % RECOVERY % RECOVERY % RECOVERY % 
-
1 100.3 100.7 99.2 97.0 96.5 
2 102.0 103.0 104 . 104.0 106.0 
3 100.0 99.9 96.6 93.1 95.8 
4 101 .0 III .0 107.0 109.0 109.0 
5 100.9 '99.5 99.3 96.4 94.2 
6 99.7 100.8 100.7 96.4 96.0 
7 100.0 104.2 103 .3 99.5 103 .8 
8 101 .0 9B.5 105.0 104.0 104 .0 
9 100.7 9B.5 97.6 102.5 94.6 
10 103 .3 105.2 105.3 103.3 99.7 
11 101 .4 105.8 101 .4 103.6 97.8 
12 100.9 100.4 100.9 96.9 99.8 
Mean = 100.9% Mean = 102.3% Mean = 101 .7% Mean = 100.5% Mean = 99.B% 
SO = ! 0.99 SO = ~ 3.70 SO, ~ 3 .25 SO = ! 4.60 SO = :4.86 
* Both of the values are derived figures, calculated by the Cobas Bio analyser. They are related 
to the initial and final absorbance readings of the reagent for the standard. 
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Table 26 - Within and between batch p~ecision data 
fo~ the endpoint assay (using the Cobas Bio analyser) 
Within batch 
n : 20 
Between batch 
n : 12 
MEAN 
rnmol/L 
5.0 
11 .0 
5.09 
10.89 
SD CV 
mmol/L % 
0.034 0.68 
o . 079 0.72 
0.16 3 .14 
0.43 3.95 
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Specificity of the mannitol assay 
MDH exhibits a high degree of specificity for mannitol as a 
substrate (25, 26). However, since in this study, the MDH 
has been used in a partially purified form, in modified 
reaction conditions, it was decided that the possibility of 
reaction with substances other than mannitol should be 
investigated. 
Figure 26 shows the structures of various sugars and sugar 
alcohols that may be found in trace quantities in urine. 
Some of these have structures similar to that of mannitol. 
To check the specificity of the assay, a series of 10 mmol/L 
aqueous mannitol containing 10 g/L of one of the compounds 
shown was prepared. These were analysed and the results 
compared with that of an aqueous mannitol standard. It can 
, 
be seen from Table 27 that the assay was not significantly 
affected by any of the substances tested: none of the sugars 
were inhibitory and none of the sugar alcohols except 
sorbitol acted as substrates. Sorbitol at a concentration 
of 55 mmol/L was equivalent to a mannitol concentration of 
0.7 mmol/L. 
Assessment of endogenous mannitol present in normal urines 
When the original colorimetric mannitol assays were used, 
one of the major problems was the high and variable blank 
values obtained when urine specimens were analysed. This 
was largely due to the poor specificity of the methods but 
it is thought that trace amounts of mannitol are excreted in 
urine (40). Having developed a very specific method which 
gives complete recovery of mannitol, an investigation of the 
-150-
F1gure 26 - Molecular structures of mann1tol and other compounds 
CHpH 
I OH OH 
HOCH 
I 
HOCH 
I 
HCOH 
I 
HCOH 
I H OH 
CHpH 
Glycerol D-mann1tol myo-!nosltol 
CH20H CHO HOCH2 CHO I I I I HCOH HCOH C=O HCOH 
I I I I 
HOCH HOCH CH HOCH 
I I I I HCOH HCOH HCOH HOCH 
I I I I HCOH HCOH HCOH HCOH 
I I I I CH20H CH20H CH20H CHpH 
D-gluC1tol D-glucose D-fructose D-galactose 
CHO CHO CHO I I I HCOH HCOH HOCH I I I HCOH HOCH HCOH I I I HCOH HCOH HCOH I I I CH20H CH20H CH20H 
D-R1bose D-Xylose D-Arab1nose 
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Figure 26 - (Continued) 
.1-----0 
OH H OH 
Cellobiose (0-fi-D-glucopyranosyl-(1-->4)-jS-D-glucopyranoside) 
.1-----0 ..1-----0 
HO 
H OH H OH 
Lactose (0- P -D-galac topyranosyl- (1-->4) - "-D-glucopyranoside) 
CHZOH 
o 0-----1.. 
H HOCHZ 
OH H OH H 
Sucrose (0- p-D-fructofuranosyl-(2-->1)-0l-D-glucopyranOside) 
CH:f>H 
J.----O ..1-----0 
H OH 
O----J 
H OH H OH 
Mal tose (0- rI... -D-glucopyranosyl- (1-->4) - P -D-glucopyranoside) 
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Table 27 - Specificity of the optimised mannitol assay 
COMPOUND ADDED 
10 g/l TO 10 mmol/l 
MANNITOL STANDARD 
Glucose 
Galactose 
Fructose 
Arabinose 
Xylose 
Sucrose 
Lactulose 
Lactose 
Maltose 
Trehalose 
Ribose 
Glycerol 
Arabitol 
Sorbitol 
Dulcitol 
Inositol 
RESULT OBTAINED -
EXPRESSED AS % OF 
EXPECTED MANNITOL 
LEVEL 
97.9 
97.5 
99.4 
96.6 
96.6 
97.9 
97.3 
96.5 
96.2 
98.5 
96.5 
97.8 
102.0 
1 03.3 
96.0 
99.6 
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true mannitol present in urine samples was carried out. 
Fifteen early morning urine specimens from normal volunteers 
were analysed. The mean mannitol concentration detected was 
0.13 mmol/L, with all results less than 0.5 mmol/L. From 
this, it was 
mannitol are 
concluded that 
present in 
although trace quantities of 
normal urine, the amount is 
insignificant for the purposes of the cellobiose/mannitol 
absorption test. 
Comparison of enzymatic results with gas liquid 
chromatography 
A comparative study of mannitol in 29 urine samples was 
carried out using the optimised'enzymatic assay and a well 
established gas liquid chromatography method (see Methods 
section). At the time of analySis, the exact concentration 
levels of mannitol in the samples was not known, but they 
were all in the range of 0-13.0 mmol/L. 
Statistical analysis using Deming's method gave a 
correlation coefficient for the two methods of 0.994, with a 
slope value of 0.956. The intercept of 0.22 was not 
significant (p (0.05). (Figure 27). 
u 
I-
Figure 27 - Comparison of mannitol concentrations 
measured by GLC and enzymatic methods 
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Optimisation of the cellobiose assay 
Source of enz~~nd concentration 
The cellobiose method of Strobel et al recommended the use 
of beta-glucosidase obtained from Sigma Chemicals at a 
concentration of 35 mg/mL. In a previous study this had 
been found to work very well in the cellobiose assay. 
although different batches of enzyme had different 
activities stated by the manufacturer, the performance of 
the assay was not affected. (NB the stated enzyme 
activity was derived using salicin as a substrate and not 
cellobiose). However, a subsequent batch of enzyme did not 
give satisfactory results. It was therefore decided to 
investigate the suitability of alternative sources of enzyme 
and the optimal concentration of enzyme for use with 
cellobiose as a substrate. 
A series of aqueous cellobiose standards were prepared over 
the range 0-0.88 mmol/L. These were assayed using beta-
glucosidase from different manufacturers and at different 
concentrations. The responses obtained are shown in Figure 
28. Enzyme obtained from BDH was used at two 
concentrations, 20 mg/mL and 4 mg/mL (88 u/mL and 18 u/mL). 
It had high background levels of glucose and showed low 
activity with the cellobiose at all concentrations. Two 
batches of enzyme from Sigma (Sigma A, batch number 38F-
4031, Sigma B, batch number 18F-4049) were assayed each at 4 
concentrations, 80 mg/L, 40 mg/L, 20 mg/L and 4 mg/L, 
(440 u/mL, 220 u/mL, 110 u/mL and 22 u/mL). 
had very low background glucose levels 
Both batches 
and showed 
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Figure 28 - The response given by different 
preparations of beta-glucosidase at different conc 
B1azynE B 2 ng/mL 
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significantly more activity at lower rather than high 
concentrations. Two batches of enzyme from Biozyme were 
assayed (Biozyme A, GSA-3, Biozyme B, GSA-2), at two 
concentrations, 2 mg/mL and 1 mg/mL (GSA-3, 40 u/mL and 
20 u/mL. GSA-2, 13 u/mL and 6.6 u/mL). Both batches 
contained significant amounts of background glucose but 
showed very good activity levels and linear responses. 
Subsequently two more batches of beta-glucosidase were 
obtained from Biozyme which had been dialysed to remove any 
sugars. These were reacted with a series of cellobiose 
standards to assess their suitability. Contiguously, the 
beta-glucosidase designated Sigma A was reassessed using 
lower concentrations of enzyme. 
The 
1.05 
Biozyme enzymes (A-S and B-S) were both 
mg/mL and 2.0 mg/mL concentrations (A-S at 
used at 
34 u/mL, 
17 u/mL and 6.8 u/mL, 8-S at 20 u/mL, 10 u/mL and 4 u/mL)~ 
It can be seen from Figure 29 that enzyme A-S gave excellent 
responses at both 1.0 mg/mL and 0.5 mg/mL. The standard 
curves are linear, with no detectable background glucose and 
approximately 100% conversion of cellobiose to glucose. At 
a concentration of 0.2 mg/mL, although the standard curve is 
linear, the conversion of cellobiose to glucose is not 
complete. Enzyme B-S gave approximately 100% conversion of 
cellobiose at a concentration of 1 mg/mL but at the lower 
concentrations the conversion was not complete. 
1.4 
1.2 
1.0 
0.8 
0.6 
..J 
"-
..... 0.4 0 
~ 
Q) 
'" 0 U 
::l 
..... 0.2 0 
-158-
Figure 29 - Activity of Biozyme A-S and B-S at different concentrations 
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Sigma A gave an acceptable level of activity at both 2 mg/mL 
and 4 mg/mL, with a linear standard curve and no detectable 
bacl:ground glucos~. AL & concentration of 0.5 mg/mL and 
0.2 mg/mL the activity was insufficient to give complete 
conversion of cellobiose to glucose (Figure 30). 
These experiments show the variation in the activity of 
enzyme using cellobiose as a substrate. The addition of 
sugars by the manufacturers during the purification process 
means that some sources of enzyme are not suitable for use 
in this assay. 
The enzyme Sigma A was suitable for use at a concentration 
of 2 mg/mL (10 u/mL) and both of the dialysed Biozyme 
enzymes (A-S and B-S) were suitable at concentrations of 
0.5 mg/mL and 1.0 mg/mL respectively (A-S at 17 u/mL and 
34 u/mL, B-S at 10 u/mL and 20 u/mL). 
Assessment of glucose measuring kits 
The measurement of glucose produced by the hydrolysis of 
cellobiose was to be carried out using a commercially 
produced glucose kit. The kits available utilise glucose 
oxidase or hexokinase and are obtainable from several 
manufacturers. All kits are simple to use, with just one 
reagent addition. However the formulations of the reagents 
vary. Several kits were tested to select one that gave good 
recoveries with urine specimens and was compatible with the 
cellobiose hydrolysis reaction. 
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Figure 30 - Activity of Sigma A beta-glucosidase at 
different concentrations 
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Seven urines from normal volunteers were spiked with 0.5 
mmolar glucose by diluting them 1:1 with a l.O mmoljL 
glucose standard made up in 0.5 molar ace~atE buffer (pH 
5.0). Non spiked urine blanks were prepared by diluting 
urines 1:1 with O.S molar acetate buffer. The spiked urines 
and urine blanks were then assayed by each of the glucose 
kits to be assessed. 
Table 28 shows that both hexokinase kits gave excellent 
recoveries (98%-104%) with all of the urines whereas the 3 
glucose oxidase kits gave very variable recoveries (60%-90%) 
and very low urine blank levels. From this, it was 
concluded that a hexokinase based reagent should be used in 
the cellobiose assay. 
Recovery of cellobiose 
Previously, both the Sigma and Randox hexokinase have been 
shown to give excellent recoveries of glucose in urine 
diluted with 0.5 moljL acetate puffer 
for the cellobiose assay). 
(the reaction buffer 
The recovery of cellobiose itself was now assessed by 
spiking urines from normal volunteers by the addition of 
solid cellobiose to the urine. The spiked urines, together 
with the original samples as blanks, were subjected to the 
cellobiose hydrolysis procedure. The glucose produced was 
measured using both hexokinase kits and the percentage 
recovery calculated. 
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Table 28 - The assessment of glucose kits for use in the cellobiose assay - recovery of glucose 
~-~---.--.. 
MANUFACTURER/RGT TYPE URINE 1 URINE 2 URINE 3 URINE 4 URINE 5 URINE 6 URINE 7 
RANDOX 
GLUCOSE OXIDASE 
Spiked urine mmol/L 0.44 0.31 0.47 0.33 0.45 0.34 o .51 
Non spiked urine mmol/L 0.01 0.01 0.02 0.03 0.01 0.04 0.07 
% Recovery 86 60 90 60 88 60 88 
TECHNICON 
GLUCOSE OXIDASE 
Spiked urine mmol/L 0.35 0.63 0.52 0.35 0.48 0.50 0.47 
Non spiked ur ine mmol/L o .01 0.16 0.10 0.02 0.01 0.04 0.01 
% Recovery 68 94 84 66 94 92 92 
BIOSTAT 
GLUCOSE; OXIDASE 
Spiked urine mmol/ L 0.33 0.58 0.42 0.31 0.45 0.45 0.40 
Non spiked ur ine mmol/L 0.01 0.14 0.08 0.01 0.01 0.05 0.05 
% Recovery 64 88 68 60 88 80 70 
SIGMA 
HEXOKINASE 
Spiked urine mmol/L 0.67 0.83 0.62 0.98 0.60 1.14 0.79 
Non spiked ur ine mmol/L 0.16 0.33 0.13 0.46 0.10 0.60 0.30 
% Recovery 102 100 98 104 100 108 98 
RANDOX 
HEXOKINASE 
Spiked urine mmol/L 0.67 0.81 0.66 0.97 0.61 1.08 0.77 
Non spiked urine mmol/L o .17 0.31 o . 17 0.48 0.12 o .0,9 0.27 
% Recovery 100 100 98 98 98 98 100 
-----
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The recoveries obtained are shown in Table 29. The Randox 
kit gave a mean recovery of 94.5% compared with 80.8% from 
the Sigma kit. 
Although initially both kits appeared to be suitable for use 
in the cellobiose assay, by virtue of the excellent glucose 
recoveries obtained, it can be seen that the Sigma kit is 
less reliable than the Randox kit when cellobiose recovery 
is measured. The reason for this would appear to be an 
interaction between the beta-glucosidase preparation and the 
hexokinase reagent which lowers the efficiency of the 
glucose measurement. The Randox hexokinase glucose kit was 
therefore selected for use in the cellobiose assay. 
Linearity of glucose measurement 
The 2 hexokinase kits gave excellent urine recoveries when 
0.5 mmo1/L glucose was added to urine. The linearity of the 
2 kits was assessed by making up a series of aqueous glucose 
standards over the range 0 to 2 mmo1/L and assaying them 
with the 2 reagents. 
Both reagents were linear over working range of the 
cellobiose assay, 0 to 2 mmo1/L (Figure 31). 
Buffer strength and pH control 
In order to ensure optimum conditions for the cellobiose 
hydrolysis reaction, it was decided to investigate whether 
the 0.1 molar acetate buffer recommended by Strobel et al 
(16) had sufficient buffering capacity to ensure that all 
Table 29 - Cellobiose recovery using different glucose HK kits 
URINE CELLOBIOSE % RECOVERY % RECOVERY 
ADDED (mmo1/L) USING SIGMA KIT USING RANDOX KIT 
1 0.5 80 92 
2 0.5 84 96 
3 0.5 84 94 
I 
4 0.5 96 100 .... 0"> 
.". 
I 
5 1 . 0 79 92 
6 1 . 5 72 95 
7 1 . 5 74 93 
8 1.5 77 95 
Mean recovery % 80.8 94.6 
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Figure 31 - Linearity of hexokinase glucose kits 
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urines were near to pH 5. 
Six early morning urine specimens from normal volunteers 
were diluted 1:1 with 0.1 molar, 
acetate buffer at pH 5.0. 
0.2 molar and 0.5 molar 
Table 30 shows that the 0.1 molar and 0.2 molar buffers were 
not sufficient to adequately control the pH of all the 
urines. The 0.5 molar buffer did appear to buffer the 
urines near to pH 5.0. It was therefore concluded that 0.5 
molar buffer should be used to prepare the beta-glucosidase 
reagent. 
"'I-'.n'--v;..e'--=-s-Ot-Oio-,g>ea=-t.=....=i-'o"'n'-__ -'o"'f'--.- the time c 0 u r s e o.",f'-_-Otc.ch",e. c ell 0 b i 0 s e 
hydroly~is reaction 
It has been determined that Biozyme A-S, B-S and Sigma A 
beta-glucosidase are suitable for use in the hydrolysis 
reaction of the cellobiose assay at concentrations of 
0.5 mg/mL, 1.0 mg/mL and 2.0 mg/mL respectively. With the 
intention of reducing the 2 hour incubation period, the time 
course of this reaction was investigated. 
A urine from a normal volunteer was spiked with 1 mmol/L 
cellobiose. This was assayed using Biozyme A-S and Sigma A 
with incubation times ranging from 15 to 120 minutes. The 
assay was also carried out using Biozyme A-S and Sigma A at 
concentrations of 3 mg/mL and 20 mg/mL respectively to 
ascertain whether increased enzyme concentrations would give 
complete hydrolysis more quickly. 
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Table 30 - The effect of different strengths of buffer on 
urine 
URINE 0.1 mol/L 0.2 mol/L o mol11 
ACETATE BUFFER ACETATE BUFFER ACETATE BUFFER 
pH OBTAINED pH OBTAINED pH OBTAINED 
1 6.24 5.47 5.07 
2 6.66 5.71 5.12 
3 5.30 5 .13 5.01 
4 5.07 5.02 5.00 
5 5.01 5 .01 5.00 
6 5.09 5.08 5.01 
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Figure 32 illustrates the different rates at which the 
reaction took place. 
of 0.5 mg/mL, the 
Using Biozyme A-S at a concentration 
hydrolysis reaction was only just 
completed after 120 minutes. At the higher concentration of 
3 mg/mL, the reaction appeared to be complete after the 
first sampling time of 15 minutes. The enzyme Sigma A, at a 
concentration of 2 mg/mL completed the reaction between 90 
and 120 minutes. At the higher concentration of 20 mg/mL, 
as expected from previous experiments it did not give 
complete hydrolysis although its reaction appeared to have 
reached an equilibrium after 15 minutes. 
Using the Biozyme A-S at the increased concentration of 3 
mg/mL, a second experiment was carried out. Urine was 
spiked with cellobiose at 0.4 mmol/L and 1.0 mmol/L. These 
2 spiked urines together with a urine blank and a 1 mmol/L 
aqueous cellobiose solution were assayed with incubation 
times ranging from 0 (immediate glucose analysis) to 30 
minutes. 
In the urine specimens and the aqueous standard, between 95% 
and 97% of the cellobiose had been hydrolysed to glucose 
after 15 minutes. After 30 minutes, 97 to 100% conversion 
had taken place (Figure 33). 
It was concluded that using the increased beta-glucosidase 
concentration, a 15 minute incubation time would be suitable 
for the routine analysis of urines. Although the hydrolysis 
was not complete at this time (95%-97% had taken place), the 
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Figure 32 - The time course of the cellobiose hydrolysis reaction 
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Figure 33 - The time course of the cellobiose hydrolysis reaction 
at different concent~ations 
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shorter incubation lessened the risk of bacterial growth in 
the reaction tube which may have consumed glucose. It also 
increased the speed of the assay consid~rably. 
Specificity of ~he cellobiose assay 
In his description of the cellobiose assay, Strobel et al 
The (14) gave little information about its specificity. 
beta-glucosidase is extracted from almonds and has been used 
in a crude extract. The presence of other enzymes in the 
preparation, for example, beta-galactosidase is likely to be 
the main cause of non specificity. 
minute traces of sugars are present. 
In normal urine, only 
In conditions such as 
coeliac disease where there is intestinal damage, larger 
quantities of oligo and disaccharides may be absorbed. In 
these cases, it is possible that some sugars may be excreted 
in the urine in excessive amounts. The effect of the 
presence of other sugars on the assay was investigated. 
Cellobiose standards at a concentration of 1 mmol/L were 
prepared in water and 10 g/L aqueous solutions of each of 
the following substances: lactose, sucrose, galactose, 
fructose and mannitol. These standards were then assayed. 
Blanks were obtained by incubating the same standards with 
acetate buffer rather than beta-glucosidase, and then 
analysing for glucose content. 
None of the blanks gave aqy reaction in the glucose assay. 
Interference due to the added sugars after incubation with 
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beta-glucosidase was variable. There was no significant 
effect due to mannitol or galactose and sucrose showed only 
a slight positive interference. Lactose exhibited a large 
positive interference whilst fructose appeared to inhibit 
the reaction. 
It is likely that the interference due to lactose is caused 
by the presence of beta-galactosidase in the crude beta-
glucosidase preparation, which catalyses the hydrolysis of 
lactose. 
Lactose Beta-galactosldas~> Galactose + Glucose 
To investigate the extent of this activity, I mmol/L 
cellobiose standards were prepared in a series of lactose 
solutions of different concentrations and assayed. 
Table 31 indicates that the interference due to lactose is 
directly proportional to its concentration. I mmol/L 
lactose gives a glucose concentration equivalent to 
0.26 mmol/L cellobiose. By the addition of varying amounts 
of lactose to a I mmol/L glucose standard followed directly 
by assay for glucose using hexokinase reagent, it was shown 
(Table 32) that the lactose has no effect on glucose 
measurement and the interference is caused solely by 
reaction in the hydrolysis step (probably the action of 
beta-galactosidase 
preparation). 
in the crude beta-glucosidase 
Table 31 - Specificity of the cellobiose assay 
STANDARD CELLOBIOSE RESULT CELLOBIOSE RESULT OBTAINED 
OBTAINED mmol/L FOR BLANKS mmol/L 
1 mmol/L cellobiose 1 .01 0.00 
I 
1 mmol/L cellobiose + 10 g/L lactose >3.5 0.01 f-' ..., 
W 
I 
1 mmol/L cellobiose + 10 g/L sucrose 1.09 0.00 
1 mmol/L cellobiose + la g/L galactose 1. 05 0.00 
1 mmol/L cellobiose + la g/L fructose 0.51 0.00 
1 mmol/L cellobiose + 10 g/L mannitol 1 .02 0.00 
Table 32 - The effect of lactose on the cellobiose assay 
STANDARDS WITH LACTOSE ADDED CELLOBIOSE OBTAINED mmol/L 
I mmol/L cellobiose 0.99 
I mmol/L cellobiose + 10 g/L lactose >3.50 
I mmol/L cellobiose + 5 g/L lactose 2.95 
I mmol/L cellobiose + 2.5 g/L lactose 2.58 1 
.... 
....., 
.". 
1 mmol/L cellobiose + 1. 25 g/L lactose 1.86 1 
I mmol/L cellobiose + 0.625 g/L lactose I .45 
I mmol/L cellobiose + 0.313 g/L lactose I .24 
I mmol/L cellobiose + 0.156 g/L lactose 1.12 
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Interference by fructose, however, was caused by inhibition 
of the glucose measurement stage. A 1 mmol/L glucose 
standard, prepared in different concentrations of fructose 
and assayed directly with hexokinase reagent (Table 33) was 
affected to the same extent as the cellobiose standard at 
the same fructose concentration (Table 31). 
Reagent stability 
In order to assess the stability of the working beta-
glucosidase reagent, a large volume of the reagent was 
prepared in the normal way and 
sterile containers at 4°C for up 
aliquots were stored in 
to 4 weeks. A series of 
spiked urine samples (aliquoted and stored at -20°C) were 
analysed at weekly intervals. Hexokinase reagent was 
prepared fresh each week for the assay. 
Table 34 shows the results obtained. It can be seen that 
there is no significant deterioration in the urinary 
recoveries or the reagent absorbance factor (a measure of 
the initial absorbance of the reagent) over the 4 week 
period. 
The hexokinase reagent was stated by the manufacturer to be 
stable for 1 week when stored at 4°C. 
Precision 
Within batch precision was assessed by analysing 20 
duplicates at 1.3 mmol/L and 0.7 mmol/L. Between batch 
precision was assessed from the results of 2 urine samples 
Table 33 - The effect of fructose and lactose on the hexokinase reaction for 
glucose measurement 
FRUCTOSE CONC IN A GLUCOSE CONC 1 mmol/L GLUCOSE WITH 
1 mmol/L GLUCOSE STD (g/L) OBTAINED mmol/L LACTOSE ADDED g/L 
0.0 1.00 0.0 
10.0 0.31 10.0 
5.0 0.52 5.0 
2.5 0.75 2.5 
1.25 0.96 1 .25 
0.625 1. 00 0.625 
GLUCOSE CONC 
OBTAINED mmol/L 
1.00 
I 
.... 
1 .01 -"'l cr-
I 
1. 01 
1 .01 
1.00 
1. 01 
Table 34 - Stability of working beta glucosidase reagent over a 4 week period 
URINE WEEK 1 WEEK 2 WEEK 3 WEEK 4 
CELLOBIOSE CELLOBIOSE CELLOBIOSE CELLOBIOSE 
% RECOVERY % RECOVERY % RECOVERY % RECOVERY 
1 94.0 94.0 94.0 96.0 
2 93.3 94.7 96.0 96.7 
3 92.0 92.0 88.0 90.0 
4 92.0 94.7 96.7 92.7 
I 
f-' 
5 85.7 89.0 10l.1 90.1 
...., 
...., 
I 
6 94.0 96.0 100.0 94.0 
7 92.0 92 .0 95.0 90.0 
8 94.7 93.3 94.0 91 .3 
9 100.0 100.0 104.0 104.0 
10 98.0 98.0 103.0 100.0 
Mean % 93.6 94.4 97.2 94.5 
recovery 
Rgt absorbance 0.86 0.86 0.83 0.84 
factor 
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stored in frozen aliquots and analysed in 10 separate 
batches. 
Table 35 shows the results obtained. The within batch CV 
was found to be less than 1% and between batch CV was 3%. 
Both figures were considered acceptable. 
Recovery of cellobiose in urine 
The percentage recovery of cellobiose was assessed by 
spiking urines with cellobiose. The spiked and original 
samples were assayed and the recoveries calculated. 
Fifteen urines were spiked with cellobiose levels from 
0.5 mmol/L to 1.5 mmol/L. The mean recovery was 95.8% with 
a CV of 2.6%. 
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Table 35 - Within and between batch precision data 
for cellobiose (automated glucose measurement) 
Within batch 
n = 20 
Between batch 
n = 10 
MEAN 
mmol/L 
1.30 
0.71 
0.96 
0.40 
SD 
mmol/L 
0.007 
0.003 
0.016 
0.013 
CV % 
0.55 
0.44 
1.64 
3.13 
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3.5. Evaluation of the HPLC method for mannitol and 
cellobiose 
The system was set up as described in the Methods section. 
Retention times were obtained for both cellobiose and 
mannitol using aqueous solutions. 
An aqueous solution containing 10 mmol/L of both mannitol 
and cellobiose was then analysed. It can be seen (Figure 
34) that a stable but noisy baseline was obtained. There 
was clear separation of the compounds, mannitol eluting 
after 8.2 minutes and cellobiose after 18 minutes. 
The attenuator and photomultiplier controls on the detector 
were adjusted in an attempt to decrease baseline noise, but 
no improvement could be achieved. 
The internal standard, ribose, was added to the aqueous 
mannitol and cellobiose solutions. This was then analysed. 
It can be seen (Figure 35) that there was clear separation 
of the internal standard from the 2 peaks of interest, with 
a retention time for ribose of 6.6 minutes. 
To assess the sensitivity and linearity of the method, 
standard curves were produced for mannitol and cellobiose 
over the range 0 mmol/L to 20 mmol/L, using the internal 
standard ribose (10 mmol/L) to calculate peak height ratios. 
An acceptable standard curve was produced for mannitol, see 
Figure 36. The method gave good linearity up to 15 mmol/L, 
Figure 34 - HPLC chromatograph showing the separation of mannitol and cellobiose 
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but at 20 mmol/L, the peak height ratio was slightly lower 
than expected. The cellobiose standard curve (Figure 37) 
was norl linear over th~ whole ~ange with very low peak 
heigh~ ra~ios indica~ing a lack of sensitivity over the 
clinically significant concentration range of 0 mmol/L to 
2 mmol/L. This lack of sensitivi~y renders ~he me~hod of 
little value in its present form. 
Although good separation of mannitol, cellobiose and ribose 
had been achieved, it was decided to investigate the ability 
of the system to separate mannitol and cellobiose from other 
similar compounds. Glucose was thought to be the most 
likely substance present in significant quantities in urine, 
that might co-elute with manni~ol (both 
similar molecular size and structure), 
more likely to co-elute with cellobiose. 
compounds having 
while lactose was 
Two aqueous solutions were prepared; one contained 10 mmol/L 
glucose and 10 mmol/L mannitol, the other contained 
10 mmol/L lactose and 10 mmol/L cellobiose. These solutions 
were analysed. 
From the first solution, only one peak was detected. This 
had a retention time of 8.2 minutes, corresponding to that 
of mannitol. From the second solution only one peak was 
detected. This had a retention time of 18.0 minutes, 
corresponding to the cellobiose peak. These results 
indicated that mannitol and glucose co-eluted, and the 
cellobiose and lactose co-eluted. This was confirmed by the 
Figure 37 - Standard curve for cellobiose by HPLC 
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analysis of a solution containing 10 
was found to have a retention time 
mmol/L glucose, which 
of 8.2 minutes. A 
solution of 10 mmol/L lactose was found to have a retention 
time of 18.0 minutes. 
In an attempt to separate the glucose and mannitol peaks, 
the concentration of acetonitrile in the mobile phase was 
increased in stages up to 95%. However, although the 
retention times were reduced, the two peaks still co-eluted. 
It was concluded that without pretreatment or 
derivatisation, separation of mannitol and glucose (and also 
of cellobiose and lactose) would not be possible. The lack 
of sensitivity of the cellobiose detection also precluded 
the use of this technique without either concentration of 
the samples prior to analysis or extensive development of 
the method to improve sensitivity. 
In order to directly compare measurement of mannitol by HPLC 
with measurement by the optimised end point enzymatic 
technique, 20 urine samples containing varying amounts of 
mannitol were assayed by both methods. 
The results are shown in Table 36 and Figure 38. As 
expected, there was considerable disparity between the 2 
methods. Statistical 
correlation coefficient 
slope value of 1.04. 
(p <0.05). 
analysis using Deming·s method gave a 
for the 2 methods of 0.905 with a 
The intercept value was - 0 .31 
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Table 36 - Comparison of mannitol levels 
obtained by enzymatic and HPLC techniques 
MANNITOL CONCENTRATION mmol/L 
URINE HPLC ENZYMATIC METHOD 
1 11 ,4 10,40 
2 10,2 11 ,00 
3 0,7 0,99 
4 10,0 10,66 
5 4,6 5,18 
6 13,9 10,92 
7 12,0 10,97 
8 0,8 0,99 
9 8,5 10,54 
10 2,0 3,61 
11 5,7 2,55 
12 0,8 1. 21 
13 12,4 13 ,03 
14 0,8 1 ,10 
15 0,8 1 ,41 
16 4,9 4,60 
17 3,1 3,25 
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Figure 38 - Comparison of mannitol concentrations measured 
by HPLC and enzymatic methods 
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3.6. Assessment of the clinical significance of the 
improved enzymatic methods for mannitol and cellobiose 
The cellobiose/mannitol absorption test is widely used as an 
initial screening test for the diagnosis of CD. Specific 
and precise methods for mannitol and cellobiose have been 
developed with the aim of giving a better separation of 
normals from people with villous atrophy. 
To investigate the effects of these improved methods, 5 hour 
urine collections were obtained from normal volunteers, 
newly diagnosed coeliacs and coeliacs on a gluten-free diet 
for 6 months, all of whom had followed the cellobiose/ 
mannitol test protocol. Aliquots of these urines were 
stored at -20°C. Analysis was carried out using the 
modified Corcoran and Page mannitol method and the enzymatic 
cellobiose method of Strobel. The results were compared 
with those obtained using the optimised enzymatic methods 
for mannitol and cellobiose. 
The cellobiose/mannitol ratios obtained from 8 healthy 
normal volunteers (Table 37) gave similar results. Using 
the original methods (the Corcoran and Page method for 
mannitol and Strobel for cellobiose), a mean of 0.018 was 
obtained with an upper limit of normal (95% confidence 
limits) of 0.034. With the optimised methods, the mean 
ratio was 0.019 with an upper limit of 0.045. These ranges 
are comparable to those obtained by other workers in the 
field (see Introduction). Considering the mannitol and 
cellobiose results separately, the mean recovery values are 
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Table 37 - Cellobiose/mannitol ratios obtained from normal volunteers - using 
original and optimised methodology 
1 
2 
3 
4 
5 
6 
7 
8 
Mean result 
SD 
Upper 95% 
confidence limit 
C/M RATIO OBTAINED 
USING ORIGINAL METHODS 
0.019 
0.024 
0.019 
0.013 
0.005 
0.012 
0.023 
0.031 
0.018 
0.008 
0.034 
C/M RATIO OBTAINED 
USING OPTIMISED METHODS 
0.009 
0.027 
0.026 
0.016 
0.004 
0.014 
0.013 
0.044 
0.019 
0.013 
0.045 
NB - Original methods used were the modified Corcoran and Page method for 
mannitol and the,cellobiose method of Strobel. 
- 19 1 -
fairly simi lar. The modified Corcoran and Page mannitol 
method gave a mean recovery of 27.97% of the given dose 
while the optimised enzymatic method gave 23.06%. The 
cellobiose method of Strobel gave a mean recovery of 0.49% 
of the given dose while the optimised enzymatic method gave 
0.40%. However, it can be seen (Table 38) that individual 
specimens sometimes gave significantly different results 
with the different methods. Since the optimised enzymatic 
method for mannitol is very specific, it is probable that 
the overall lower recoveries obtained by this method and 
individual result discrepancies are due to the presence of 
substances interfering in the Corcoran and Page method. In 
the case of cellobiose measurement, it is possible that 
individual result. discrepancies are because the greater 
buffering capacity and shorter incubation time of the 
optimised method allow more accurate measurement and reduce 
the risk of bacterial interference. 
In the newly diagnosed coeliac patients, the results 
obtained by the original and optimised methods are 
substantially different (Table 39). The mean cellobiose/ 
mannitol ratio was 0.243 using the original methods whilst 
that for the optimised method was 0.407. Considered as 
single parameters, the cellobiose and mannitol recoveries 
also varied. The mean mannitol recovery obtained using the 
Corcoran and Page method was 10.66% of the given dose 
compared with 5.55% obtained using the optimised method 
(Table 40). The mean cellobiose recovery using the method 
of Strobel was 2.05% of the given dose compared with 1.44% 
Table 38 - Recoveries obtained for mannitol and cellobiose using original and optimised 
methods (data from normal volunteers) 
Mean 27.97 23.06 0.49 0.40 
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Table 39 - Cellobiose/mannitol ratios obtained from newly 
diagnosed coeliac patients - using original and optimised 
methods 
URINE C/M RATIO OBTAINED C/M RATIO OBTAINED 
WITH ORIGINAL METHOD WITH OPTIMISED METHOD 
1 0.533 0.785 
2 0.952 1 .016 
3 0.502 0.744 
4 0.038 0.041 
5 0.512 0.441 
6 0.320 0.585 
7 o . 113 o .231 
8 0.028 0.318 
9 0.082 0.294 
10 0.489 0.832 
1 1 0.017 0.060 
12 0.068 o . 123 
13 o . 113 0.228 
14 0.245 o .661 , 
15 0.173 0.721 
16 0.193 0.198 
17 o . 162 o . 189 
18 o .103 0.232 
19 0.686 1 .503 
20 o .496 0.606 
21 0.098 0.133 
22 0.086 o .104 
23 0.056 0.147 
24 o . 156 o . 195 
25 0.051 o .109 
26 0.060 0.077 
Mean result 0.243 0.407 
, 
I , 
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Table 40 - Mannitol levels obtained from newly diagnosed 
coeliac patients - using original and optimised methods 
URINE 
1 
2 
3 
4 
5 
MANNITOL LEVELS OBTAINED 
USING MODIFIED 
CORCORAN & PAGE METHOD 
% RECOVERY 
3.90 
5.48 
8.48 
25.95 
8.03 
MANNITOL LEVELS OBTAINED 
USING OPTIMISED 
ENZYME METHOD 
% RECOVERY 
1.30 
1.87 
2 .15 
10.63 
4.35 
1-
6 9.60 
7 13.05 
1.83 
10.55 
I 
8 11 .55 
9 8.40 
4.06 
3.85 
I 
10 5.58 1 .53 
! 11 15.75 8.06 
12 12.15 5.78 
13 7.43 3.67 
14 6.70 1 .83 
15 5.48 2.08 
16 4.05 3.93 
17 20.63 17.75 
18 18.69 4.49 
19 10.50 3.93 
20 10.50 8.60 
21 14.10 10.41 
22 14.10 11 .58 
23 14.70 7.14 
24 9.00 3.44 
25 7.65 4.08 
26 5.83 5.32 
Mean result 10.66 5.55 
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obtained using the optimised method (Table 41). Specimens 
from the patients who had followed a gluten-free diet for 6 
months after being diagnosed as having CD, also gave 
significantly different results when using the different 
methods (Table 42). The mean cellobiose/mannitol ratio was 
0.061 using the original methods whilst that for the 
optimised methods was 0.098. 
The significance of these different results on the diagnosis 
of coeliac disease is illustrated in Figure 39. Using the 
original methods, out of a total of 26 patients, 2 have a 
cellobiose/mannitol ratio of less than 0.034, which would be 
considered normal. A further 5 patients have ratios between 
0.04 and 0.06, a potentially borderline ratio. However, 
using the optimised methods, 2 patients have ratios between 
0.04 and 0.06 but none have a ratio below 0.04. 
Figure 40 shows a comparison of the ratios obtained using 
the optimised methods, in the 3 categories of specimen; 
normal controls, untreated coeliacs and treated coeliacs. 
There is little overlap between normals and untreated 
coeliacs while it can be seen that the treated coeliacs 
overlap the normal and untreated groups. Figure 41 shows 
the cellobiose/mannitol ratios obtained in a group of 
individual patients where it was possible to obtain 
specimens both at the time of diagnosis (untreated) and 
after 6 months on a gluten-free diet. It can be seen that 
in all cases the cellobiose/mannitol ratio had decreased, 
although in 2 cases, this was only marginal. The decrease 
Table 41 - Cellobiose levels obtained from newly 
diagnosed coeliac patients - using original and 
optimised methods 
URINE CELLOBIOSE LEVELS CELLOBIOSE LEVELS 
OBTAINED USING OBTAINED USING 
STROBEL'S METHOD OPTIMISED METHOD 
% RECOVERY % RECOVERY 
1 2.08 1.02 
2 5.22 1.90 
3 4.26 1,60 
4 0.98 0.44 
5 4 .11 1 .92 
6 3.07 1.07 
7 1.48 2.44 
8 0.32 1 .29 
9 0.69 1.13 
10 2.73 1.56 
11 0.27 0.48 
12 0.71 o .71 
13 0.84 0.836 
14 1.64 1.03 
15 0.95 1.50 
16 0.78 0.78 
17 3.35 3.35 
18 1.92 0.49 
19 7.20 3.51 
20 5.20 5.21 
21 1.38 1. 38 
22 1 .20 1 .21 
23 0.83 1.05 
24 1 .40 0.67 
25 0.39 0.39 
26 0.35 0.41 
Mean result 2.05 1 .44 
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Table 42 - Cellobiose/mannitol ratios obtained from.treated 
coeliac patients - using original and optimised methods 
-----
URINE C/M RATIO OBTAINED C/M RATIO OBTAINED 
USING ORIGINAL METHODS USING OPTIMISED METHODS 
1 0.160 0.199 
2 0.081 o . 109 
3 o . 112 0.531 
4 0.007 0.021 
5 0.118 0.292 
6 0.015 0.018 
7 0.045 0.130 
8 0.185 0.185 
9 o .035 0.030 
10 0.050 0.032 
11 0.079 0.105 
12 0.049 0.080 
13 0.001 0.008 
14 0.047 0.054 
15 0.007 0.010 
16 0.097 0.186 
17 0.036 0.046 
18 0.014 0.020 
19 o .041 0.044 
20 o .116 0.059 
21 0.058 0.038 
22 0.009 0.009 
23 0.030 0.038 
24 0.073 0.100 
Mean x 0.061 0.098 
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F1gure 39 
- Compar1son of cellob1ose/mann1tol rat10s obta1ned 1n newly 
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Figure 40 - Comparison of cellobiose/mannitol ratios obtained 
in normal controls, newly diagnosed coeliacs and treated 
coeliacs 
• 
1.016 
• 1.503 
• 0.832 
• 
• • 
• 
• 
• 
• 
• 
• 
.. • 
I 
• I 
• ! • • • • 
Normal controls Untreated CD Treated CD 
0.8 
0.7 
0.6 
0.5 
0.4 
0 
..... 
...., 
(1j 
t.. 
..... 
0.3 
0 
...., 
..... 
<: 
<: 
(1j 
8 
"-Q) 0.2 
'" 0 
..... 
£J 
0 
..... 
..... 
Q) 
u 0.1 
-200-
Figure 41 - Comparison of cellobiose/mannitol ratios obtained 
in a group of patients followed up 6 months after diagnosis of CD 
1.016 
1.020 
Newly diagnosed CD After 6 months on GFD 
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in cellobiose/mannitol ratio corresponded with general 
clinical improvements in most patients. It is thought that 
the speed at which the cellobiose/mannitol ratio drops is 
dependent both on the initial severity of the intestinal 
lesions and also the compliance of the patient to the 
gluten-free diet. 
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4. DISCUSSION 
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4. DISCUSSION 
The first stage in the development of an enzymatic mannitol 
assay was the growth of Leuconostoc mesenteroides for the 
production of mannitol dehydrogenase. The medium and growth 
conditions of Yamanaka were used but the constantly low 
yields of cells led to investigation of other media and 
variation of growth conditions. The brain heart infusion 
medium with 10% added glucose in static culture gave the 
greatest yield of cells per litre of medium. It was not 
known why the medium suggested by Yamanaka gave such poor 
yields. 
Having obtained acceptable yields of bacteria, ·the 
disruption and purification processes were commenced .. 
Grinding cells with levigated alumina was found to be an 
unsatisfactory technique giving poor and variable disruption 
of cells. Other disruption methods were also found to be 
unsatisfactory. Ultrasonic breakage gave much more reliable 
results. Although the ultrasonic probe required for this 
technique is not available in many routine laboratories, it 
is a simple method to use, which is suitable for both small 
experimental quantities or larger commercial batches. 
The enzyme pur.ification process described by Yamanaka was 
found to be technically difficult, time consuming, labour 
intensive and impractical for small batches of cells. The 
adaptation of the column chromatography technique of 
Blomquist was found to be a major improvement, being quicker 
and simpler to perform for both small and large batches. 
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The initial problem of loss of activity when using the 
column technique was thought to be due to cofactor depletion 
but the addition of extra cofactors did not restore 
activity. It was interesting to note that the use of EDTA 
seemed to be causing the inhibitory effect, since according 
to established literature, the structures of MDH from 
Leuconostoc mesenteroides and Lactobacillus brevis (used by 
Blomquist) are ~ similar (26). 
The initial development of a kinetic assay for mannitol was 
adopted because it enabled the use of small amounts of 
enzyme and because kinetic assays are widely used as routine 
techniques. The Michaelis-Menton constant for the 
conversion of mannitol to fructose is high, so the use of 
reaction rate analysis rather than end/point conversion 
seemed to be the simplest method of measurement. However 
the consistently poor recoveries and small absorbance 
changes led to the decision to investigate an end point 
method. By utilising a secondary reaction involving 
hexokinase and ATP to convert fructose to fructose-6-
phosphate, the problems of the high Michaelis-Menton 
constant and product inhibition were overcome. The use of a 
strong buffer to control the reaction pH was essential due 
to the narrow optimum pH range of the enzyme. The secondary 
reaction had the advantage that it increased the pH range 
for maximum enzyme activity, particularly at the low end of 
the range (between pH 8.0 and pH 8.4). This is relevant 
because urine specimens tend to be slightly acidic and will 
therefore push the reaction pH downwards if the buffering 
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capacity is insufficlent. After optimisation, an assay was 
produced which was robust, precise, accurate; gave good 
recoveries and correlated well with the GLC method of Laker 
and Mount. The action of MDH is very specific. The trace 
quantities of mannitol, detected in urine when mannitol had 
not been ingested were insignificant so there was·no need to 
correct for this. 
The cellobiose method involved development of the method of 
Strobel. The most important improvements were the stronger 
buffer used to ensure optimum enzyme activity and the 
shorter incubation time which decreases the likelihood of 
bacterial growth in the incubation mixture and makes the 
assay more convenient. The investigation of specificity 
showed the inhibitory effect of fructose on the measurement 
of glucose by hexokinase and also, the positive interference 
by lactose. This was due to the presence of galactosidase 
in the beta-glucosidase preparation rather than lack of 
specificity of the beta-glucosidase itself. Use of 
chromographically purified enzyme would minimise this 
problem but is not feasible in practice because of the high 
cost. Clinically the detection of lactose in addition to 
cellobiose increases the separation of normals from patients 
with villous atrophy (the disaccharide lactose is probably 
leaked into the urine by the same mechanisms as cellobiose). 
The method gives good precision and recovery values. 
----~----------
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Although only a short amount of time was spent on 
investigation of an HPLC method for cellobiose and mannitol, 
it was obvious that without major development a specific and 
sensitive method for both analytes would not be possible. 
The need for derivatisation and concentration of samples 
meant that it is unlikely that HPLC could be considered as 
an alternative to the enzymatic methods in routine use. 
The results obtained using the optimised methods for 
cellobiose and mannitol differ markedly from those obtained 
with the original methods. 
In the case of mannitol, the enzymatic method gives overall 
lower results than the colorimetric method. This is thought 
to be due to the greater specificity of the enzymatic assay. 
In the Corcoran and Page method, there is a varying amount 
of non _ specific interference which can give rise to 
significant inaccuracy particularly at low concentrations of 
mannitol. The optimised cellobiose assay produces results 
which are mainly higher than the original method. The use 
of the stronger buffer which ensures maximum enzymatic 
activity, may explain this. The shorter incubation time, 
helping to prevent bacterial growth, may reduce bacterial 
consumption of glucose and also prevent the splitting of 
disaccharides by bacterial enzymes. 
The combination of the optimised methods gave a much better 
separation of normals and abnormals then the original 
methods did, in the cellobiose/mannitol absorption test. 
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This combination also fulfilled most of the requirements for 
routine assays. The methods are easy to use, adaptable to 
most common analysers and produce results quickly. The 
reagents are simple to prepare and quite stable. There is 
no doubt that these methods are quicker and more convenient 
than any other methods for cellobiose and mannitol currently 
available. 
The clinical use of the cellobiose/mannitol absorption test 
to diagnose CD is widely recognised (see Introduction) but 
its use has been restricted by the poor methodologies 
available. However, 
the chance for much 
the optimised methods developed give 
wider use of the test and means that 
screening patients for CD is feasible in practice. 
The use of alpha-gliadin antibody assays to screen for CD is 
also increasing in popularity as more robust assays become 
available. Although this test has a very high predictive 
value for CD (over 90%), it is an invasive test and a small 
group of patients seem not to have raised antibody levels 
although showing clinical signs of CD. Theoretically, the 
basis of the 
an immune 
alpha-gliadin antibody assay is measurement of 
response whereas the cellobiose/mannitol 
absorption test is a direct estimation of intestinal 
function. The cellobiose/mannitol test is less specific for 
CD than the gliadin assay so it can be used to screen for 
proximal Crohn's disease and other malabsorption syndromes 
as well as CD. In the outpatient gastroenterology clinic, 
the availability of the cellobiose/mannitol test, especially 
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in conjunction with other tests such as the gliadin antibody 
test, gives the physician a simple, efficient and cost 
effective means of screening patients. The duodenal biopsy 
can be used to follow up abnormal or equivocal results to 
give a definitive diagnosis. Once the diagnosis has been 
made and the patient introduced to the gluten-free diet, 
follow up testing using the cellobiose/mannitol absorption 
test can be carried out to assess improvement in intestinal 
function and also compliance to the diet. As intestinal 
permeability returns to normal, the cellobiose/mannitol 
ratio decreases and approaches the normal range. The 
greater reliability of the optimised assays is particularly 
useful at this stage, when the ratios may only change by 
small amounts. The ability to monitor patients at regular 
intervals over a long period of time is particularly useful 
for maintaining good compliance to the gluten-free diet. 
The association of mucosal lesions with the development of 
intestinal lymphomas and carcinomas means that patients are 
recommended to remain on the diet even when they are 
clinically in remission. The availability of a regular test 
gives some patients added motivation to stay on the diet 
( 41 ) . 
The mannitol assay has applications other than in the 
investigation of intestinal permeability. Mannitol has been 
used for its osmotic properties in brain surgery and to 
prevent post operative renal failure and as a free radical 
scavenger. Although the method developed in this study was 
used for urine mannitol levels, its adaptation for the 
analysis of serum, plasma or other specimens should be 
possible. 
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CONCLUSION 
The aim of t.his study, to develop simple methods for 
measurement of cellobiose and mannitol, has been fulfilled. 
The enzymatic methods described perform well and are within 
the scope of most routine clinical laboratories. However, 
the alternative approach to analysis, ie, the use of HPLC, 
does not appear to be easily developed into a method that 
could be contemplated as a screening test. Without the 
purchase of specialised equipment such as a PAD detector, 
pre-treatment of specimens to derivatise or to concentrate 
seems inevitable. 
The clinical data resulting from this study confirms the 
ability of the cellobiose/mannitol test to distinguish 
villous atrophy from normal intestinal function. The 
greater accuracy of the optimised enzymatic methods improves 
the reliability of the results and suggests that the 
cellobiose/mannitol absorption test could well be a cost 
effective means of screening for CD. Further work could be 
carried out to extend the scope of the absorption test by 
looking at other groups of patients with related intestinal 
disorders, for example, Crohn's disease and ulcerative 
colitis. 
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